Ten-year experience of radical cystectomy in one center: retrospective analysis and oncological results ; Десятилетний опыт радикальной цистэктомии в одном центре: ретроспективный анализ и онкологические результаты

Συγγραφείς: M. V. Berkut, A. K. Nosov, М. В. Беркут, А. К. Носов

Πηγή: Cancer Urology; Том 20, № 4 (2024); 60-74 ; Онкоурология; Том 20, № 4 (2024); 60-74 ; 1996-1812 ; 1726-9776

Θεματικοί όροι: неоцистис, radical cystectomy, lymph node dissection, urinary diversion, neobladder, радикальная цистэктомия, лимфаденэктомия, уродеривация

Περιγραφή αρχείου: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1830/1578; Ferlay J., Ervik M., Lam F. et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer, 2024. Available at: https://gco.iarc.who.int/today (accessed 12 Jule 2024).; Состояние онкологической помощи населению России в 2022 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2023. 239 с.; Тимофеев И.В., Алексеева Г.Н., Петкау В.В. и др. Продолжительность жизни больных метастатическим раком мочевого пузыря в Российской Федерации: результаты многоцентрового регистрового исследования URRU. Онкоурология 2021;17(3):102–9. DOI:10.17650/1726-9776-2021-17-3-102-109; Клинические рекомендации по лечению рака мочевого пузыря, 2024. 143 с.; Stein J.P., Lieskovsky G., Cote R. et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19(3):666–75. DOI:10.1200/JCO.2001.19.3.666; Комяков Б.К., Гулиев Б.Г., Сергеев А.В. и др. Выживаемость больных раком мочевого пузыря после радикальной цистэктомии. Онкоурология 2016;12(1):29–35. DOI:10.17650/1726-9776-2016-12-1-29-35; Перепечай В.А., Васильев О.Н., Спицын И.М., Коган М.И. Анализ достоверности факторов прогноза выживаемости после радикальной цистэктомии. Экспериментальная и клиническая урология 2016;(1):28–34.; Hautmann R.E., de Petriconi R.C., Pfeiffer C., Volkmer B.G. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol 2012;61(5):1039–47. DOI:10.1016/j.eururo.2012.02.028; Cheung G., Dasgupta P., Guru K.A. et al. Minimally invasive cystectomy approaches in the treatment of bladder cancer. Exp Rev Anticancer Ther 2012;12(6):733–41. DOI:10.1586/era.12.52; Носов А.К., Рева С.А., Джалилов И.Б., Петров С.Б. Радикальная цистэктомия при раке мочевого пузыря: сравнение ранних хирургических осложнений при лапароскопической, открытой и видеоассистированной операции. Онкоурология 2015;11(3):71–8. DOI:10.17650/1726-9776-2015-11-3-71-78; Challacombe B.J., Bochner B.H., Dasgupta P. et al. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. Eur Urol 2011;60(4):767–75. DOI:10.1016/j.eururo.2011.05.012; Smith A.B., Raynor M., Amling C.L. et al. Multi-institutional analysis of robotic radical cystectomy for bladder cancer: periopetative outcomes and complications in 227 patients. J Laparoendosc Adv Surg Tech A 2012;22:17–21.; Parra R.O., Andrus C.H., Jones J.P., Boullier J.A. Laparoscopic cystectomy: initial report on a new treatment for the retained bladder. J Urol 1992;148(4):1140–4. DOI:10.1016/s0022-5347(17)36843-x; Sánchez de Badajoz E., Gallego Perales J.L., Reche Rosado A. et al. Cistectomía radical y conducto ileal laparoscópico [Radical cystectomy and laparoscopic ileal conduit]. Arch Esp Urol 1993;46(7):621–4.; Дубровин В.Н., Табаков А.В., Мельник Г.А. и др. Первый опыт применения лапароскопической цистэктомии в лечении инвазивного рака мочевого пузыря. Онкоурология 2008;(1):29–33. DOI:10.17650/1726-9776-2008-4-1-29-33; Перлин Д.В., Александров И.В., Зипунников В.П., Шманев А.О. Лапароскопическая радикальная цистэктомия: ключевые моменты. Онкоурология 2018;14(1):136–43. DOI:10.17650/1726-9776-2018-14-1-136-143; Котов С.В., Хачатрян А.Л., Журавлева А.К., Саргсян Ш.М. Сравнительный анализ периоперационных результатов открытой и лапароскопической радикальной цистэктомии с формированием илеокондуита. Экспериментальная и клиническая урология 2022;15(1):38–44. DOI:10.29188/2222-8543-2022-15-1-38-44; Lisiński J., Kienitz J., Tousty P. et al. Comparison of laparoscopic and open radical cystectomy for muscle-invasive bladder cancer. Int J Environ Res Public Health 2022;19(23):15995. DOI:10.3390/ijerph192315995; Abol-Enein H., El-Baz M., Abd El-Hameed M.A. et al. Lymph node involvement in patients with bladder cancer treated with radical cystectomy: a patho-anatomical study – a single center experience. J Urol 2004;172(5 Pt 1):1818–21. DOI:10.1097/01.ju.0000140457.83695.a7; Gschwend J.E., Heck M.M., Lehmann J. et al. Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial. Eur Urol 2019;75(4):604–11. DOI:10.1016/j.eururo.2018.09.047; Lerner S.P., Tangen C., Svatek R.S. et al. SWOG S1011: a phase III surgical trial to evaluate the benefit of a standard versus an extended lymphadenectomy performed at time of radical cystectomy for muscle invasive urothelial cancer. JCO 2023;41:4508. DOI:10.1200/JCO.2023.41.16_suppl.4508; Shariat S.F., Lee R., Lowrance W.T., Bochner B.H. The effect of age on bladder cancer incidence, prognosis and therapy. Aging Health 2010;6(5):649–59. DOI:10.2217/ahe.10.61; Prout G.R. Jr, Wesley M.N., Yancik R. et al. Age and comorbidity impact surgical therapy in older bladder carcinoma patients: a population-based study. Cancer 2005;104(8):1638–47. DOI:10.1002/cncr.21354; Bizzarri F.P., Scarciglia E., Russo P. et al. Elderly and bladder cancer: the role of radical cystectomy and orthotopic urinary diversion. Urologia 2024;91(3):500–4. DOI:10.1177/03915603241240644; Sogni F., Brausi M., Frea B. et al. Morbidity and quality of life in elderly patients receiving ileal conduit or orthotopic neobladder after radical cystectomy for invasive bladder cancer. Urology 2008;71(5):919–23. DOI:10.1016/j.urology.2007.11.125; Ahmadi H., Skinner E.C., Simma-Chiang V. et al. Urinary functional outcome following radical cystoprostatectomy and ileal neobladder reconstruction in male patients. J Urol 2013;189(5):1782–8. DOI:10.1016/j.juro.2012.11.078; Табаков А.В., Дубровин В.Н. Лапароскопическая цистэктомия с ортототопической энтеропластикой мочевого пузыря из мини-доступа в лечении больных раком мочевого пузырь. Медицинский альманах 2012;2(23):59–63.; Yang L.S., Shan B.L., Shan L.L. et al. A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer. Surg Oncol 2016;25(3):281–97. DOI:10.1016/j.suronc.2016.05.027; https://oncourology.abvpress.ru/oncur/article/view/1830

Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/1830
https://doi.org/10.17650/1726-9776-2024-20-4-60-74

МЕТОДЫ АНАЛИЗА ВЫЖИВАЕМОСТИ ПАЦИЕНТОВ ПОСЛЕ РАДИКАЛЬНОЙ ЦИСТЭКТОМИИ

Θεματικοί όροι: Kaplan-Meier curves, classification trees, рак мочевого пузыря, деревья классификации, bladder cancer, кривые Каплана-Мейера, радикальная цистэктомия, выживаемость, radical cystectomy, survival, 3. Good health

APPLICATION OF GRAPHICAL METHODS IN THE ANALYSIS OF SURVIVAL OF PATIENTS WITH BLADDER CANCER

Πηγή: Экологические системы и приборы.

Θεματικοί όροι: ФАКТОРЫ РИСКА, РАК МОЧЕВОГО ПУЗЫРЯ, РАДИКАЛЬНАЯ ЦИСТЭКТОМИЯ, ИНДЕКС КОМОРБИДНОСТИ CHARLSON, CHARLSON COMORBIDITY INDEX, RISK FACTORS, ВЫЖИВАЕМОСТЬ, КУРЕНИЕ, RADICAL CYSTECTOMY, SMOKING, BLADDER CANCER

Brachytherapy for organ-preserving treatment of bladder cancer ; Брахитерапия при органосохраняющем лечении рака мочевого пузыря

Συγγραφείς: I. N. Zaborskiy, K. N. Safiullin, E. I. Smolenov, E. O. Shchukina, V. S. Chaykov, A. V. Troyanov, I. O. Dementiev, O. B. Karyakin, S. A. Ivanov, A. D. Kaprin, И. Н. Заборский, К. Н. Сафиуллин, Е. И. Смоленов, Е. О. Щукина, В. С. Чайков, А. В. Троянов, И. О. Дементьев, О. Б. Карякин, С. А. Иванов, А. Д. Каприн

Πηγή: Cancer Urology; Том 20, № 2 (2024); 140-147 ; Онкоурология; Том 20, № 2 (2024); 140-147 ; 1996-1812 ; 1726-9776

Θεματικοί όροι: органосохраняющая лучевая терапия, muscle-invasive bladder cancer, radical cystectomy, organ-preserving radiation therapy, мышечно-инвазивный рак мочевого пузыря, радикальная цистэктомия

Περιγραφή αρχείου: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1823/1543; Barringer B.S. Radium treatment of carcinoma of the bladder. Ann Surg 1921;74(6):751–67.; Orton C.G., Seyedsadr M., Somnay A. Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation. Int J Radiat Oncol Biol Phys 1991;21(6):1425–34. DOI:10.1016/0360-3016(91)90316-v; Herger C., Sauer H.R. Radium treatment of cancer of bladder. Report of 267 cases. Am J Roentgenol 1942;47:909–15.; Van der Werf-Messing B. Treatment of carcinoma of the bladder with radium. Clin Radiol 1965;16:16–26. DOI:10.1016/s0009-9260(65)80029-0; Van der Werf-Messing B., Star W.M., Menon R.S. T3NXM0 carcinoma of the urinary bladder treated by the combination of radium implant and external irradiation. A preliminary report. Int J Radiat Oncol Biol Phys 1980;6(12):1723–5. DOI:10.1016/0360-3016(80)90259-x; Wijnmaalen A., van der Werf-Messing B.H. Factors influencing the prognosis in bladder cancer. Int J Radiat Oncol Biol Phys 1986;12(4):559–65. DOI:10.1016/0360-3016(86)90063-5; Morson A.C. Observations on twenty-three cases of carcinoma of the bladder treated by radium. Br Med J 1929;1(3570):1038–9. DOI:10.1136/bmj.1.3570.1038; Lenz M., Cahill G.F. The treatment of cancer of the bladder by radium needles. Am J Roentgenol Radium Ther 1947;58(4):486–92.; Barringer B.S. Twenty-five years of radon treatment of cancer of the bladder. J Am Med Assoc 1947;135(10):616–8. DOI:10.1001/jama.1947.02890100010003; Van der Werf-Messing B., Menon R.S., Hop W.C.J. Cancer of the urinary bladder category T2, T3, (NXM0) treated by interstitial radium implant: second report. Int J Radiat Oncol Biol Phys 1983;9(4):481–5. DOI:10.1016/0360-3016(83)90064-0; Van der Werf-Messing B.H., Van Putten W.L. Carcinoma of the urinary bladder category T2,3NXM0 treated by 40 Gy external irradiation followed by cesium137 implant at reduced dose (50 %). Int J Radiat Oncol Biol Phys 1989;16(2):369–71. DOI:10.1016/0360-3016(89)90332-5; Mazeron J.J., Crook J., Chopin D. et al. Conservative treatment of bladder carcinoma by partial cystectomy and interstitial iridium 192. Int J Radiat Oncol Biol Phys 1988;15(6):1323–30. DOI:10.1016/0360-3016(88)90227-1; De Neve W., Lybeert M.L., Goor C. et al. T1 and T2 carcinoma of the urinary bladder: Long term result with external, preoperative, or interstitial radiotherapy. Int J Radiat Oncol Biol Phys 1992;23(2):299–304. DOI:10.1016/0360-3016(92)90745-4; Battermann J.J., Tierie A.H. Results of implantation for T1 and T2 bladder tumours. Radiother Oncol 1986;5(2):85–90. DOI:10.1016/s0167-8140(86)80161-x; Pernot M., Hubert J., Guillemin F. et al. Combined surgery and brachytherapy in the treatment of some cancers of the bladder (partial cystectomy and interstitial iridium-192). Radiother Oncol 1996;38(2):115–20. DOI:10.1016/0167-8140(96)82354-1; Wijnmaalen A., Helle P.A., Koper P.C. et al. Muscle invasive bladder cancer treated by transurethral resection, followed by external beam radiation and interstitial iridium-192. Int J Radiat Oncol Biol Phys 1997;39(5):1043–52. DOI:10.1016/s0360-3016(97)00375-1; De Crevoisier R., Ammor A., Court B. et al. Bladder-conserving surgery and interstitial brachytherapy for lymph node negative transitional cell carcinoma of the urinary bladder: Results of a 28-year single institution experience. Radiother Oncol 2004;72(2):147–57. DOI:10.1016/j.radonc.2004.06.002; Nieuwenhuijzen J.A., Pos F., Moonen L.M.F. et al. Survival after bladder-preservation with brachytherapy versus radical cystectomy; a single institution experience. Eur Urol 2005;48(2):239–45. DOI:10.1016/j.eururo.2005.03.022; Rozan R., Albuisson E., Donnarieix D. et al. Interstitial iridium-192 for bladder cancer (A multicentric survey: 205 patients). Int J Radiat Oncol Biol Phys 1992;24(3):469–77. DOI:10.1016/0360-3016(92)91061-q; Brenner D.J., Hall E.J. Conditions for the equivalence of continuous to pulsed low dose rate brachytherapy. Int J Radiat Oncol Biol Phys 1991;20(1):181–90. DOI:10.1016/0360-3016(91)90158-z; Soete G., Coen V., Verellen D. et al. A feasibility study of high dose rate brachytherapy in solitary urinary bladder cancer. Int J Radiat Oncol Biol Phys 1997;38(4):743–7. DOI:10.1016/s0360-3016(97)00063-1; Pos F.J., Horenblas S., Lebesque J. et al. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer. Int J Radiat Oncol Biol Phys 2004;59(3):696–705. DOI:10.1016/j.ijrobp.2003.11.040; Blank L.E.C.M., Koedooder K., van Os R. et al. Results of bladderconserving treatment, consisting of brachytherapy combined with limited surgery and external beam radiotherapy, for patients with solitary T1-T3 bladder tumors less than 5 cm in diameter. Int J Radiat Oncol Biol Phys 2007;69(2):454–8. DOI:10.1016/j.ijrobp.2007.03.014; Koning C.C.E.,Blank L.E.C.M., Koedooder C. et al. Brachytherapy after external beam radiotherapy and limited surgery preserves bladders for patients with solitary pT1-pT3 bladder tumors. Ann Oncol 2012;23(11):2948–53. DOI:10.1093/annonc/mds126; Smits G.A.H.J., Van der Steen-Banasik E., Oosterveld B. et al. Minimal invasive surgery and brachytherapy as bladder preserving multimodality treatment in selected solitary MIBC. Eur Urol Suppl 2019;18(1):e814. DOI:10.1016/S1569-9056(19)30594-9; Van der Steen-Banasik E.M., Smits G.A.H.J., Oosterveld B.J. et al. The Curie-Da Vinci connection: 5-years’ experience with laparoscopic (robot-assisted) implantation for high-dose-rate brachytherapy of solitary T2 bladder tumors. Int J Radiat Oncol Biol Phys 2016;95(5):1439–42. DOI:10.1016/j.ijrobp.2016.03.029; Bus S.J.E.A., Leus N.G., Oosterveld B.J. et al. An evaluation of our experience in position verification of catheters used for interstitial high-dose-rate brachytherapy of solitary bladder tumors. Brachytherapy 2018;17(1):24–30. DOI:10.1016/j.brachy.2017.01.013; Voskuilen C.S., Bosschieter J., van Werkhoven E. et al. Long-term survival and complications following bladder-preserving brachytherapy in patients with cT1-T2 bladder cancer. Radiother Oncol 2019;141:130–6. DOI:10.1016/j.radonc.2019.09.026; Van Onna I.E.W., Oddens J.R., Kok E.T. et al. External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients. Eur Urol 2009;56(1):113–22. DOI:10.1016/j.eururo.2008.07.043; Van der Steen-Banasik E., Ploeg M., Witjes J.A. et al. Brachytherapy versus cystectomy in solitary bladder cancer: A case control, multicentre, East-Netherlands study. Radiother Oncol 2009;93(2):352–357. DOI:10.1016/j.radonc.2009.04.020; Aluwini S., Van Rooij P.H.E., Kirkels W.J. et al. Bladder function preservation with brachytherapy, external beam radiation therapy, and limited surger in bladder cancer patients: Long-term results. Int J Radiat Oncol Biol Phys 2014;88(3):611–7. DOI:10.1016/j.ijrobp.2013.11.227; Krasnow R.E., Drumm M., Roberts H.J. et al. Clinical Outcomes of Patients with Histologic Variants of Urothelial Cancer Treated with Trimodality Bladder-sparing Therapy. Eur Urol 2017;72(1):54–60. DOI:10.1016/j.eururo.2016.12.002; Han B., Liang S., Jing Y. et al. Organ preservation for muscleinvasive bladder cancer by preoperative intra-arterial chemotherapy and transurethral resection. Med Oncol 2014;31(4):912. DOI:10.1007/s12032-014-0912-9; Mak R.H., Hunt D., Shipley W.U. et al. Long-term outcomes in patients with muscle-invasive bladder cancer after selective bladder-preserving combined-modality therapy: a pooled analysis of Radiation Therapy Oncology Group protocols 8802, 8903, 9506, 9706, 9906, and 0233. J Clin Oncol 2014;32(34):3801–9. DOI:10.1200/JCO.2014.57.5548; Pieters B.R., Van der Steen-Banasik E., Smits G.A. et al. GEC-ESTRO/ACROP recommendations for performing bladdersparing treatment with brachytherapy for muscle-invasive bladder carcinoma. Radiother Oncol 2017;122(3):340–6. DOI:10.1016/j.radonc.2016.12.022; Richtlijn Blaascarcinoom Nederlandstalige samenvatting van de EAU guidelines on bladder cancer. Available at: http://www.nvu.nl; https://oncourology.abvpress.ru/oncur/article/view/1823

Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/1823
https://doi.org/10.17650/1726-9776-2024-20-2-140-147

Мультицентровое рандомизированное исследование пролонгированной антибиотикопрофилактики при цистэктомии в клиниках, работающих по протоколу раннего послеоперационного восстановления (ERAS)

Συγγραφείς: М. В. Беркут, А. М. Беляев, Т. Ю. Галунова, Н. И. Тяпкин, С. А. Рева, А. К. Носов

Συνεισφορές: Исследование проведено при поддержки гранта РакФонда от 22.05.2022 г.

Πηγή: Malignant tumours; Том 14, № 3s1 (2024); 63-71 ; Злокачественные опухоли; Том 14, № 3s1 (2024); 63-71 ; 2587-6813 ; 2224-5057

Θεματικοί όροι: ERAS протокол, радикальная цистэктомия, антибиотикопрофилактика, инфекционные осложнения

Περιγραφή αρχείου: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/1349/956; Witjes J.A., Bruins H.M., Cathomas R. et.al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol 2021;79(1):82–104. https://doi.org/10.1016/j.eururo.2020.03.055; Hautmann R.E., de Petriconi R.C., Volkmer B.G. Lessons learned from 1,000 neobladders: the 90-day complication rate. J Urol 2010;184(3):990–1235. https://doi.org/10.1016/j.juro.2010.05.037; Даренков С.П., Кривобородов Г.Г., Котов С.В. Осложнения радикальной цистэктомии с орто- и гетеротопической кишечной пластикой (обзор литературы). Вестник РГМУ 2013;4:49–53.; Lawrentschuk N., Colombo R., Hakenberg O.W., et al. Prevention and management of complications following radical cystectomy for bladder cancer. Eur Urol 2010;57(6):983–1001. https://doi.org/10.1016/j.eururo.2010.02.024; Носов А.К., Рева С.А., Джалилов И.Б., Петров С.Б. Радикальная цистэктомия при раке мочевого пузыря: сравнение ранних хирургических осложнений при лапароскопической, открытой и видеоассистированyой операции. Онкоурология 2015;11(3):71–78. https://doi.org/10.17650/1726-9776-2015-11-3-71-78; Котов С.В., Хачатрян А.Л., Котова Д.П. и соавт. Анализ результатов применения протокола ERAS в реальной клинической практике при радикальной цистэктомии (первое проспективное мультицентровое исследование в России). Урология 2019;6:60–66. https://dx.doi.org/10.18565/urology.2019.6.60-66; Peerbocus M., Wang Z.J. Enhanced Recovery After Surgery and Radical Cystectomy: A Systematic Review and Meta-Analysis. Res Rep Urol 2021;13:535–547. https://dx.doi.org/10.2147/RRU.S307385; Профилактика инфекций области хирургического вмешательства. Клинические рекомендации под редакцией Брико Н.И., Божкова С.А., Брусина Е.Б. и соавт. Н. Новгород: Изд-во «Ремедиум Приволжье» 2018:72; Асланов Б.И., Зуева Л.П., Колосовская Е.Н. и соавт. Принципы организации периоперационной антибиотикопрофилактики в учреждениях здравоохранения. Федеральные клинические рекомендации. М; 2014:42; Altemeier W.A., Burke J.F., Pruitt B.A.Jr., Sanduskiy W.R. Manual on control of infection in surgical patients. Philadelphia: Lippincott 1972:20–32; Атдуев В.А., Гасраталиев В.Э., Ледяев Д.С., Шевелев И.С., Бельский В.А. Предикторы послеоперационных осложнений радикальной цистэктоми. Онкология, Журнал им. П.А. Герцена 2019;8(5):348–357. https://dx.doi.org/10-17116/onkolog20198051348; Беркут М. В, Мамижев Э.М., Галунова Т.Ю. и соавт. Клиническое исследование: мультицентровое исследование по использованию превентивной антибиотикотерапии при цистэктомии в условиях раннего послеоперационного восстановления (исследование MACS). Вопросы онкологии 2023;69(3):415–421. https://doi.org/10.37469/0507-3758-2023-69-3-415-421; Berkut M.V., Belyaev A.M., Galunova T.Yu., et al. Effectiveness of Prolonged Antibiotic Prophylaxis in Radical Cystectomy: Preliminary Analysis of the MACS Randomized Clinical Trial. Bladder Cancer 2024;1–12. https://doi.org/10.3233/BLC-240012; Berkut M.V., Belyaev A.M., Galunova T.Y. et.al. Prolonged 120-h meropenem antibiotic prophylaxis in radical cystectomy compared to 24h standard antibiotic prophylaxis: Final analysis of the randomized clinical trial. Arab J Urol 2024;22(4):235–242. https://doi.org/10.1080/20905998.2024.2373399; Volland H., Girlich D., Laguide M., et al. Improvement of the Immunochromatographic NG-Test Carba 5 Assay for the Detection of IMP Variants Previously Undetected. Antimicrob Agents Chemother 2019;64(1):e01940–19. https://doi.org/10.1128/AAC.01940-19; Van Hemelrijck M., Thorstenson A., Smith P. et.al. Risk of in-hospital complications after radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients. BJU Int 2013;112(8):1113–1120. https://doi.org/110.1111/bju.12239; Clifford T.G., Katebian B., Van Horn C.M., et al. Urinary tract infections following radical cystectomy and urinary diversion: a review of 1133 patients. World J Urol 2018;36(5):775–781. https://doi.org/10.1007/s00345-018-2181-2; Pellegrino F., Leni R., Basile G., et al. Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center. World J Urol 2024;42(1):270. https://doi.org/10.1007/s00345-024-04970-x; Williams S.B., Cumberbatch M.G.K., Kamat A.M., et al. Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysis. Eur Urol 2020;78(5):719–730. https://doi.org/10.1016/j.eururo.2020.06.039; Черненькая Т.В., Борисова Л.А., Воробьева Т.Ю. и соавт. Карбапенемазы, продуцируемые полирезистентными штаммами Klebsiella pneumoniae, выделенными от пациентов реанимационного профиля. Журнал им. Н.В. Склифосовского Неотложная медицинская помощь 2024;13(1):22–28. https://doi.org/10.23934/2223-9022-2024-13-1-22-28; Radko M, Guzek A, Syryło T, Rybicki Z, Zieliński H. Preliminary trial of 24 vs 72 hour perioperative meropenem in patients with ESBL-producing Enterobacterales bacteriuria scheduled for urological procedures. Cent European J Urol 2022;75(2):209–215. https://doi.org/10.5173/ceju.2022.0109; Невежина А.В. Карбапенемазы как фактор устойчивости к антибактериальным препаратам. Acta biomedica scientifica 2020;5(6):95–105. https://doi.org/10.29413/ABS.2020-5.6.11; Полищук А.Г., Якубович Е.И., Полухина О.В. и соавт. Карбапенемаза-продуцирующие грамотрицательные бактерии в специализированном стационаре Санкт-Петербурга. Инфекция и иммунитет 2017;7(2):181–192. https://doi.org/10.15789/2220-7619-2017-2-181-192; Эйдельштейн М.В., Шайдуллина Э.Р., Иванчик Н.В. и соавт. Антибиотикорезистентность клинических изолятов Klebsiella pneumoniae и Escherichia coli в стационарах России: результаты многоцентрового эпидемиологического исследования. Клиническая микробиология и антимикробная химиотерапия 2024;26(1):67–78. https://doi.org/10.36488/cmac.2024.1.67-78; Platt, J.J., Ramanathan, M.L., Crosbie, R.A., et al. C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer. Ann Surg Oncol 2012;19(13):4168–4177. https://doi.org/10.1245/s10434-012-2498-9; Charbonneau J., Brind ’Amour A., Sideris L., et al. Predictive Value of C-Reactive Protein for Infectious Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Single-Center Prospective Study. Ann Surg Oncol 2024. https://doi.org/10.1245/s10434-024-15986-3; Straatman J., Harmsen A.M.K., Cuesta M.A. et.al. Predictive Value of C-Reactive Protein for Major Complications after Major Abdominal Surgery: A Systematic Review and Pooled-Analysis. PLoS One 2015;10(7):e0132995. https://doi.org/10.1371/journal.pone.0132995; https://www.malignanttumors.org/jour/article/view/1349

Διαθεσιμότητα: https://www.malignanttumors.org/jour/article/view/1349
https://doi.org/10.18027/2224-5057-2024-14-3s1-63-71

Рак мочевого пузыря

Συγγραφείς: А. А. Румянцев, П. В. Булычкин, М. И. Волкова, О. А. Гладков, Р. А. Зуков, В. Б. Матвеев, Д. А. Носов

Πηγή: Malignant tumours; Том 14, № 3s2-2 (2024); 221-241 ; Злокачественные опухоли; Том 14, № 3s2-2 (2024); 221-241 ; 2587-6813 ; 2224-5057

Θεματικοί όροι: иммунотерапия, трансуретральная резекция, внутрипузырная терапия, радикальная цистэктомия, тримодальная терапия, химиотерапия

Περιγραφή αρχείου: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/1390/995; https://www.malignanttumors.org/jour/article/view/1390

Διαθεσιμότητα: https://www.malignanttumors.org/jour/article/view/1390
https://doi.org/10.18027/2224-5057-2024-14-3s2-1.2-09

Survival in patients with muscle-invasive bladder cancer after robot-assisted radical cystectomy with intracorporeal urinary derivation ; Выживаемость пациентов с мышечно-инвазивным раком мочевого пузыря после робот-ассистированной радикальной цистэктомии с интракорпоральной деривацией мочи

Συγγραφείς: V. N. Pavlov, M. F. Urmantsev, M. R. Bakeev, В. Н. Павлов, М. Ф. Урманцев, М. Р. Бакеев

Πηγή: Creative surgery and oncology; Том 14, № 1 (2024); 5-12 ; Креативная хирургия и онкология; Том 14, № 1 (2024); 5-12 ; 2076-3093 ; 2307-0501

Θεματικοί όροι: интракорпоральная деривация мочи, robot-assisted radical cystectomy, pelvic lymphadenectomy, oncologic outcomes, survival analysis, intracorporeal urinary derivation, робот-ассистированная радикальная цистэктомия, тазовая лимфаденэктомия, онкологические результаты, анализ выживаемости

Περιγραφή αρχείου: application/pdf

Relation: https://www.surgonco.ru/jour/article/view/910/585; Richters A., Aben K.K.H., Kiemeney L.A.L.M. Th e global burden of urinary bladder cancer: an update. World J Urol. 2020;38(8):1895–904. DOI:10.1007/s00345-019-02984-4; Lenis A.T., Lec P.M., Chamie K., Mshs M.D. Bladder cancer: a review. JAMA. 2020;324(19):1980–91. DOI:10.1001/jama.2020.17598; Chang S.S., Bochner B.H., Chou R., Dreicer R., Kamat A.M., Lerner S.P., et al. Treatment of nonmetastatic muscle-invasive bladder cancer: American urological association/American society of clinical oncology/American society for radiation oncology/Society of urologic oncology clinical practice guideline summary. J Oncol Pract. 2017;13(9):621–5. DOI:10.1200/JOP.2017.024919; Tan W.S., Lamb B.W., Tan M.Y., Ahmad I., Sridhar A., Nathan S., et al. In-depth critical analysis of complications following robot-assisted radical cystectomy with intracorporeal urinary diversion. Eur Urol Focus. 2017;3(2–3):273–9. DOI:10.1016/j.euf.2016.06.002; van Hemelrijck M., Th orstenson A., Smith P., Adolfsson J., Akre O. Risk of in-hospital complications aft er radical cystectomy for urinary bladder carcinoma: population-based follow-up study of 7608 patients. BJU Int. 2013;112(8):1113–20. DOI:10.1111/bju.12239; Alfred Witjes J., Lebret T., Compérat E.M., Cowan N.C., De Santis M., Bruins H.M., et al. Updated 2016 EAU Guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol. 2017;71(3):462–75. DOI:10.1016/j.eururo.2016.06.020; Parekh D.J., Reis I.M., Castle E.P., Gonzalgo M.L., Woods M.E., Svatek R.S., et al. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet. 2018;391(10139):2525–36. DOI:10.1016/S0140-6736(18)30996-6; Menon M., Hemal A.K., Tewari A., Shrivastava A., Shoma A.M., El-Tabey N.A., et al. Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion. BJU Int. 2003;92(3):232–6. DOI:10.1046/j.1464-410x.2003.04329.x; Mitra A.P., Cai J., Miranda G., Bhanvadia S., Quinn D.I., Schuckman A.K., et al. Management trends and outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder: evolution of the university of Southern California experience over 3,347 cases. J Urol. 2022;207(2):302–13. DOI:10.1097/JU.0000000000002242; Tamhankar A.S., Th urtle D., Hampson A., El-Taji O., Th urairaja R., Kelly J.D., et al. Radical cystectomy in England from 2013 to 2019 on 12,644 patients: an analysis of national trends and comparison of surgical approaches using Hospital Episode Statistics data. BJUI Compass. 2021;2(5):338–47. DOI:10.1002/bco2.79; Liu H., Zhou Z., Yao H., Mao Q., Chu Y., Cui Y., et al. Robot-assisted radical cystectomy vs open radical cystectomy in patients with bladder cancer: a systematic review and meta-analysis of randomized controlled trials. World J Surg Oncol. 2023;21(1):240. DOI:10.1186/s12957-023-03132-4; Riveros C., Ranganathan S., Nipper C., Lim K., Brooks M., Dursun F., et al. Open vs. robot-assisted radical cystectomy with extracorporeal or intracorporeal urinary diversion for bladder cancer A pairwise metaanalysis of outcomes and a network meta-analysis of complications. Can Urol Assoc J. 2023;17(3):E75–85. DOI:10.5489/cuaj.8096; Tyritzis S.I., Collins J.W., Wiklund N.P. Th e current status of robotassisted cystectomy. Indian J Urol. 2018;34(2):101–9. DOI:10.4103/iju.IJU_355_17; Wijburg C.J., Hannink G., Michels C.T.J., Weijerman P.C., Issa R., Tay A., et al. Learning curve analysis for intracorporeal robot-assisted radical cystectomy: results from the EAU Robotic urology section scientifi c working group. Eur Urol Open Sci. 2022;39:55–61. DOI:10.1016/j.euros.2022.03.004; Hussein A.A., May P.R., Jing Z., Ahmed Y.E., Wijburg C.J., Canda A.E., et al. Outcomes of intracorporeal urinary diversion aft er robotassisted radical cystectomy: results from the International robotic cystectomy consortium. J Urol. 2018;199(5):1302–11. DOI:10.1016/j.juro.2017.12.045; Han J.H., Ku J.H. Robot-assisted radical cystectomy: Where we are in 2023. Investig Clin Urol. 2023;64(2):107–17. DOI:10.4111/icu.20220384; Martin A.S., Corcoran A.T. Contemporary techniques and outcomes of robotic assisted radical cystectomy with intracorporeal urinary diversion. Transl Androl Urol. 2021;10(5):2216–32. DOI:10.21037/tau.2019.09.45; Павлов В.Н., Урманцев М.Ф., Бакеев М.Р. Успехи роботассистированной цистэктомии в лечении мышечно-инвазивного рака мочевого пузыря. Онкоурология. 2022;18(2):123–8. DOI:10.17650/1726-9776-2022-18-2-123-128; Cacciamani G.E., Medina L., Lin-Brande M., Tafuri A., Lee R.S., Ghodoussipour S., et al. Timing, patterns and predictors of 90-day readmission rate aft er robotic radical cystectomy. J Urol. 2021;205(2):491–9. DOI:10.1097/JU.0000000000001387; Павлов В.Н., Урманцев М.Ф., Бакеев М.Р. Робот-ассистированная радикальная цистэктомия с интракорпоральным формированием гетеротопического неоцистиса: опыт осложнений одного центра. Вестник урологии. 2023;11(2):92–8. DOI:10.21886/2308-6424-2023-11-2-92-98; Maibom S.L., Joensen U.N., Poulsen A.M., Kehlet H., Brasso K., Røder M.A. Short-term morbidity and mortality following radical cystectomy: a systematic review. BMJ Open. 2021;11(4):e043266. DOI:10.1136/bmjopen-2020-043266; Feng D., Liu S., Tang Y., Yang Y., Wei W., Han P. Comparison of perioperative and oncologic outcomes between robot-assisted and laparoscopic radical cystectomy for bladder cancer: a systematic review and updated meta-analysis. Int Urol Nephrol. 2020;52(7):1243–54. DOI:10.1007/s11255-020-02406-0; Mortezavi A., Crippa A., Kotopouli M.I., Akre O., Wiklund P., Hosseini A. Association of open vs robot-assisted radical cystectomy with mortality and perioperative outcomes among patients with bladder cancer in Sweden. JAMA Netw Open. 2022;5(4):e228959. DOI:10.1001/jamanetworkopen.2022.8959; Yuh B., Wilson T., Bochner B., Chan K., Palou J., Stenzl A., et al. Systematic review and cumulative analysis of oncologic and functional outcomes aft er robot-assisted radical cystectomy. Eur Urol. 2015;67(3):402–22. DOI:10.1016/j.eururo.2014.12.008; Hussein A.A., Elsayed A.S., Aldhaam N.A., Jing Z., Osei J., Kaouk J., et al. Ten-year oncologic outcomes following robot-assisted radical cystectomy: results from the International robotic cystectomy consortium. J Urol. 2019;202(5):927–35. DOI:10.1097/JU.0000000000000386; Venkatramani V., Reis I.M., Castle E.P., Gonzalgo M.L., Woods M.E., Svatek R.S., et al. Predictors of recurrence, and progression-free and overall survival following open versus robotic radical cystectomy: analysis from the RAZOR Trial with a 3-year followup. J Urol. 2020;203(3):522–9. DOI:10.1097/JU.0000000000000565; https://www.surgonco.ru/jour/article/view/910

Διαθεσιμότητα: https://www.surgonco.ru/jour/article/view/910
https://doi.org/10.24060/2076-3093-2024-14-1-5-12

Парціальна цистектомія з ад’ювантною хіміо- або променевою терапією при м’язово-інвазивному раку сечового міхура (огляд літератури)

Συγγραφείς: Navrotskyi, B.M.

Πηγή: Practical oncology; Том 2, № 4 (2019); 40-44
Практическая онкология-Praktična onkologìâ; Том 2, № 4 (2019); 40-44
Практична онкологія-Praktična onkologìâ; Том 2, № 4 (2019); 40-44

Θεματικοί όροι: тримодальна терапія раку сечового міхура, м'язово-інвазивний рак сечового міхура, парціальна цистектомія, радикальна цистектомія, трехмодальная терапия рака мочевого пузыря, мышечно-инвазивный рак мочевого пузыря, парциальная цистэктомия, радикальная цистэктомия, trimodal bladder cancer therapy, muscle invasive bladder cancer, partial cystectomy, radical cystectomy, 3. Good health

Περιγραφή αρχείου: application/pdf

Σύνδεσμος πρόσβασης: http://oncology.zaslavsky.com.ua/article/download/195185/197116
http://oncology.zaslavsky.com.ua/article/view/195185

Robot-assisted radical cystectomy with intracorporeal heterotopic neocystis: a single-centre experience of complications ; Робот-ассистированная радикальная цистэктомия с интракорпоральным формированием гетеротопического неоцистиса: опыт осложнений одного центра

Συγγραφείς: V. N. Pavlov, M. F. Urmantsev, M. R. Bakeev, В. Н. Павлов, М. Ф. Урманцев, М. Р. Бакеев

Συνεισφορές: The study was not sponsored, Исследование не имело спонсорской поддержки

Πηγή: Urology Herald; Том 11, № 2 (2023); 92-98 ; Вестник урологии; Том 11, № 2 (2023); 92-98 ; 2308-6424 ; 10.21886/2308-6424-2023-11-2

Θεματικοί όροι: осложнения, robot-assisted radical cystectomy, intracorporeal urine derivation, neobladder, complications, робот-ассистированная радикальная цистэктомия, интракорпоральное отведение мочи

Περιγραφή αρχείου: application/pdf

Relation: https://www.urovest.ru/jour/article/view/724/470; World Health Organization. International Agency for Research on Cancer. The Global Cancer Observatory. (December, 2020). Bladder Source: Globocan 2020. Accessed on June, 6, 2023. https://gco.iarc.fr/today/data/factsheets/cancers/30-Bladder-fact-sheet.pdf; Alfred Witjes J, Lebret T, Compérat EM, Cowan NC, De Santis M, Bruins HM, Hernández V, Espinós EL, Dunn J, Rouanne M, Neuzillet Y, Veskimäe E, van der Heijden AG, Gakis G, Ribal MJ. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer. Eur Urol. 2017;71(3):462-475. DOI:10.1016/j.eururo.2016.06.020; Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz GE, Donat SM, Coleman JA, Mathew S, Vickers A, Schnorr GC, Feuerstein MA, Rapkin B, Parra RO, Herr HW, Laudone VP. Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: A Randomized Clinical Trial. Eur Urol. 2015;67(6):1042-1050. DOI:10.1016/j.eururo.2014.11.043; Bochner BH, Sjoberg DD, Laudone VP; Memorial Sloan Kettering Cancer Center Bladder Cancer Surgical Trials Group. A randomized trial of robot-assisted laparoscopic radical cystectomy. N Engl J Med. 2014;371(4):389-90. DOI:10.1056/NEJMc1405213; Павлов В.Н., Урманцев М.Ф., Юдина Ю.В., Бакеев М.Р. Место робот-ассистированной цистэктомии в лечении мышечно-инвазивного рака мочевого пузыря. Урология. 2021;6:141–144. DOI:10.18565/urology.2021.6.141-144; Павлов В.Н., Урманцев М.Ф., Бакеев М.Р. Успехи робот-ассистированной цистэктомии в лечении мышечно-инвазивного рака мочевого пузыря. Онкоурология. 2022;18(2):123-128. DOI:10.17650/1726-9776-2022-18-2-123-128; Bochner BH, Dalbagni G, Marzouk KH, Sjoberg DD, Lee J, Donat SM, Coleman JA, Vickers A, Herr HW, Laudone VP. Randomized Trial Comparing Open Radical Cystectomy and Robot-assisted Laparoscopic Radical Cystectomy: Oncologic Outcomes. Eur Urol. 2018;74(4):465-471. DOI:10.1016/j.eururo.2018.04.030; Zamboni S, Soria F, Mathieu R, Xylinas E, Abufaraj M, D Andrea D, Tan WS, Kelly JD, Simone G, Gallucci M, Meraney A, Krishna S, Konety BR, Antonelli A, Simeone C, Baumeister P, Mattei A, Briganti A, Gallina A, Montorsi F, Rink M, Aziz A, Karakiewicz PI, Rouprêt M, Koupparis A, Scherr DS, Ploussard G, Sooriakumaran P, Shariat SF, Moschini M; European Association of Urology - Young Academic Urologists (EAU-YAU), Urothelial carcinoma working group. Differences in trends in the use of robot-assisted and open radical cystectomy and changes over time in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration. BJU Int. 2019;124(4):656-664. DOI:10.1111/bju.14791; International Bladder Cancer Nomogram Consortium; Bochner BH, Kattan MW, Vora KC. Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer. J Clin Oncol. 2006;24(24):3967-72. Erratum in: J Clin Oncol. 2007;25(11):1457. DOI:10.1200/JCO.2005.05.3884; Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C, Raj G, Bochner BH, Dalbagni G, Herr HW, Donat SM. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55(1):164-74. DOI:10.1016/j.eururo.2008.07.031; Tan WS, Lamb BW, Tan MY, Ahmad I, Sridhar A, Nathan S, Hines J, Shaw G, Briggs TP, Kelly JD. In-depth Critical Analysis of Complications Following Robot-assisted Radical Cystectomy with Intracorporeal Urinary Diversion. Eur Urol Focus. 2017;3(2-3):273-279. DOI:10.1016/j.euf.2016.06.002; Johar RS, Hayn MH, Stegemann AP, Ahmed K, Agarwal P, Balbay MD, Hemal A, Kibel AS, Muhletaler F, Nepple K, Pattaras JG, Peabody JO, Palou Redorta J, Rha KH, Richstone L, Saar M, Schanne F, Scherr DS, Siemer S, Stökle M, Weizer A, Wiklund P, Wilson T, Woods M, Yuh B, Guru KA. Complications after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2013;64(1):52-7. DOI:10.1016/j.eururo.2013.01.010; Nazmy M, Yuh B, Kawachi M, Lau CS, Linehan J, Ruel NH, Torrey RR, Yamzon J, Wilson TG, Chan KG. Early and late complications of robot-assisted radical cystectomy: a standardized analysis by urinary diversion type. J Urol. 2014;191(3):681-7. DOI:10.1016/j.juro.2013.10.022; https://www.urovest.ru/jour/article/view/724

Διαθεσιμότητα: https://www.urovest.ru/jour/article/view/724
https://doi.org/10.21886/2308-6424-2023-11-2-92-98

Рак мочевого пузыря

Συγγραφείς: О. А. Гладков, П. В. Булычкин, М. И. Волкова, Р. А. Зуков, В. Б. Матвеев, Д. А. Носов

Πηγή: Malignant tumours; Том 13, № 3s2-1 (2023); 620-639 ; Злокачественные опухоли; Том 13, № 3s2-1 (2023); 620-639 ; 2587-6813 ; 2224-5057

Θεματικοί όροι: иммунотерапия, трансуретральная резекция, внутрипузырная терапия, радикальная цистэктомия, тримодальная терапия, химиотерапия

Περιγραφή αρχείου: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/1234/868; https://www.malignanttumors.org/jour/article/view/1234

Διαθεσιμότητα: https://www.malignanttumors.org/jour/article/view/1234
https://doi.org/10.18027/2224-5057-2023-13-3s2-1-620-639

ICG fluorescence imaging for the evaluation of lymph nodes in bladder cancer ; Возможности ICG-флуоресцентной визуализации лимфатических узлов у больных раком мочевого пузыря

Συγγραφείς: V. N. Pavlov, M. F. Urmantsev, M. R. Bakeev, В. Н. Павлов, М. Ф. Урманцев, М. Р. Бакеев

Πηγή: Malignant tumours; Том 13, № 1 (2023); 17-23 ; Злокачественные опухоли; Том 13, № 1 (2023); 17-23 ; 2587-6813 ; 2224-5057

Θεματικοί όροι: радикальная цистэктомия, ICG fluorescence, radical cystectomy, ICG-флуоресценция

Περιγραφή αρχείου: application/pdf

Relation: https://www.malignanttumors.org/jour/article/view/1100/777; Witjes J.A., Compérat E., Cowan N.C., De Santis M., Gakis G., Lebret T., et al. EAU guidelines on muscle-invasive and metastatic bladder cancer : summary of the 2013 guidelines. Eur Urol. 2014; 65 (4) : 778–792.; Mehlen P., Puisieux A., Metastasis : a question of life or death. Nat Rev Cancer 2006; 6 : 449–58.; Nguyen D.X., Bos P.D., Massagué J. Metastasis : from dis semination to organ-specific colonization. Nat Rev Cancer 2009; 9 : 274–84.; Pini G., Matin S.F., Suardi N., Desai M., Gill I., Porter J., et al. Robot assisted lymphadenectomy in urology : pelvic, retroperitoneal and inguinal. Minerva Urol Nefrol 2017; 69 : 38–55.; Polom W., Markuszewski M., Cytawa W., Czapiewski P., Lass P., Matuszewski M. Fluorescent Versus Radioguided Lymph Node Mapping in Bladder Cancer. Clin Genitourin Cancer. 2017; 15 (3) : e405-e409.; Leissner J., Ghoneim M.A., Abol-Enein H., Thüroff J.W., Franzaring L., Fisch M., et al. Extended radical lymphadenectomy in patients with urothelial bladder cancer : results of a prospective multicenter study. J Urol 2004; 171 : 139–44.; Inoue S., Shiina H., Mitsui Y., Yasumoto H., Matsubara A., Igawa M. Identification of lymphatic pathway involved in the spread of bladder cancer : Evidence obtained from fluorescence navigation with intraoperatively injected indocyanine green. Can Urol Assoc J. 2013; 7 (5–6) : E322-E328.; Polom K., Murawa D., Rho Y.S., Nowaczyk P., Hünerbein M., Murawa P. Current trends and emerging future of indocyanine green usage in surgery and oncology : a literature review. Cancer 2011; 117 : 4812–22.; Xiong L., Gazyakan E., Yang W., Engel H., Hünerbein M., Kneser U., et al. Indocyanine green fluorescence-guided sentinel node biopsy : a meta-analysis on detection rate and diagnostic performance. Eur J Surg Oncol 2014; 40 : 843–9.; Абоян И.А., Пакус Д.И., Пакус С.М., Грачев С.В., Березин К.В. Робот-ассистированная тазовая лимфаденэктомия с использованием ICG-диагностики у пациентов с раком предстательной железы. Онкоурология 2018; 14 (3) : 51–7.; Imboden S., Papadia A., Nauwerk M., McKinnon B., Kollmann Z., Mohr S., et al. A Comparison of Radiocolloid and Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients with Cervical Cancer Undergoing Laparoscopic Surgery. Ann Surg Oncol. 2015; 22 (13) : 4198–4203.; Papadia A., Imboden S., Siegenthaler F., Gasparri M.L., Mohr S., Lanz S., et al. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer. Ann Surg Oncol. 2016; 23 (7) : 2206–2211.; Hachey K.J., Gilmore D.M., Armstrong K.W., Harris S.E., Hornick J.L., Colson Y.L., et al. Safety and feasibility of near-infrared image-guided lymphatic mapping of regional lymph nodes in esophageal cancer. J Thorac Cardiovasc Surg. 2016; 152 : 546–554.; Kinami S., Oonishi T., Fujita J., Tomita Y., Funaki H., Fujita H., et al. Optimal settings and accuracy of indocyanine green fluorescence imaging for sentinel node biopsy in early gastric cancer. Oncol Lett. 2016; 11 : 4055–4062.; Currie A.C., Brigic A., Thomas-Gibson S., Suzuki N., Moorghen M., Jenkins J.T., et al. A pilot study to assess near infrared laparoscopy with indocyanine green (ICG) for intraoperative sentinel lymph node mapping in early colon cancer. Eur J Surg Oncol. 2017; 43 (11) : 2044–2051.; Pathak R.A., Hemal A.K. Intraoperative ICG-fluorescence imaging for robotic-assisted urologic surgery : current status and review of literature. Int Urol Nephrol. 2019; 51 (5) : 765–771.; Schaafsma B.E., Mieog J.S., Hutteman M., van der Vorst J.R., Kuppen P.J., Löwik C.W., et al. The clinical use of indocyanine green as a near-infrared fluorescent contrast agent for image-guided oncologic surgery. J Surg Oncol. 2011; 104 (3) : 323–332.; Schols R.M., Bouvy N.D., van Dam R.M., Stassen L.P. Advanced intraoperative imaging methods for laparoscopic anatomy navigation : an overview. Surg endosc 2013; 27 (6) : 1851–9.; Chennamsetty A., Zhumkhawala A., Tobis S.B., Ruel N., Lau C.S., Yamzon J., et al. Lymph node fluorescence during robot-assisted radical prostatectomy with indocyanine green : prospective dosing analysis. Clin Genitourin Cancer. 2017; 15 : e529-e534.; Buda A., Bussi B., Di Martino G., Di Lorenzo P., Palazzi S., Grassi T., et al. Sentinel lymph node mapping with near-infrared fluorescent imaging using indocyanine green : a new tool for laparoscopic platform in patients with endometrial and cervical cancer. J Minim Invasive Gynecol. 2016; 23 : 265–269.; Buda A., Dell’Anna T., Vecchione F., Verri D., Di Martino G., Milani R. Near-infrared sentinel lymph node mapping with indocyanine green using the VITOM II ICG exoscope for open surgery for gynecologic malignancies. J Minim Invasive Gynecol. 2016; 23 : 628–632.; Buda A., Passoni P., Corrado G., Bussi B., Cutillo G., Magni S., et al. Near-infrared fluorescence-guided sentinel node mapping of the ovary with indocyanine green in a minimally invasive setting : a feasible study. J Minim Invasive Gynecol. 2017; 24 : 165–170.; van Manen L., Handgraaf H.J.M., Diana M., Dijkstra J., Ishizawa T., Vahrmeijer A.L., et al. A practical guide for the use of indocyanine green and methylene blue in fluorescence-guided abdominal surgery. J Surg Oncol. 2018; 118 (2) : 283–300.; Ishizawa T., Masuda K., Urano Y., Kawaguchi Y., Satou S., Kaneko J., et al. Mechanistic background and clinical applications of indocyanine green fluorescence imaging of hepatocellular carcinoma. Ann Surg Oncol. 2014; 21 : 440–448.; Aoki T., Yasuda D., Shimizu Y., Odaira M., Niiya T., Kusano T., et al. Image-guided liver mapping using fluorescence navigation system with indocyanine green for anatomical hepatic resection. World J Surg. 2008; 32 : 1763–1767.; Boogerd L.S., Handgraaf H.J., Lam H.D., Huurman V.A., Farina-Sarasqueta A., Frangioni J.V., et al. Laparoscopic detection and resection of occult liver tumors of multiple cancer types using real-time near-infrared fluorescence guidance. Surg Endosc. 2017; 31 : 952–961.; Peloso A., Franchi E., Canepa M.C., Barbieri L., Briani L., Ferrario J., et al. Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer. HPB. 2013; 15 : 928–934.; Abo T., Nanashima A., Tobinaga S., Hidaka S., Taura N., Takagi K., et al. Usefulness of intraoperative diagnosis of hepatic tumors located at the liver surface and hepatic segmental visualization using indocyanine green-photodynamic eye imaging. Eur J Surg Oncol. 2015; 41 : 257–264.; DeLong J.C., Chakedis J.M., Hosseini A., Kelly K.J., Horgan S., Bouvet M. Indocyanine green (ICG) fluorescence-guided laparoscopic adrenalectomy. J Surg Oncol. 2015; 112 : 650–653.; Sound S., Okoh A.K., Bucak E., Yigitbas H., Dural C., Berber E. Intraoperative tumor localization and tissue distinction during robotic adrenalectomy using indocyanine green fluorescence imaging : a feasibility study. Surg Endosc. 2016; 30 : 657–662.; Manny T.B., Pompeo A.S., Hemal A.K. Robotic partial adrenalectomy using indocyanine green dye with near-infrared imaging : the initial clinical experience. Urology. 2013; 82 : 738–742.; Dip F., Roy M., Lo Menzo E., Simpfendorfer C., Szomstein S., Rosenthal R.J. Routine use of fluorescent incisionless cholangiography as a new imaging modality during laparoscopic cholecystectomy. Surg Endosc. 2015; 29 : 1621–1626.; Dip F.D., Asbun D., Rosales-Velderrain A., Lo Menzo E., Simpfendorfer C.H., Szomstein S., et al. Cost analysis and effectiveness comparing the routine use of intraoperative fluorescent cholangiography with fluoroscopic cholangiogram in patients undergoing laparoscopic cholecystectomy. Surg Endosc. 2014; 28 : 1838–1843.; Siddighi S., Yune J.J., Hardesty J. Indocyanine green for intraoperative localization of ureter. Am J Obstet Gynecol. 2014; 211 : 436e431–436e432.; Lee Z., Moore B., Giusto L., Eun DD. Use of indocyanine green during robot-assisted ureteral reconstructions. Eur Urol. 2015; 67 : 291–298.; Kumagai Y., Ishiguro T., Haga N., Kuwabara K., Kawano T., Ishida H. Hemodynamics of the reconstructed gastric tube during esophagectomy : assessment of outcomes with indocyanine green fluorescence. World J Surg. 2014; 38 : 138–143.; Koyanagi K., Ozawa S., Oguma J., Kazuno A., Yamazaki Y., Ninomiya Y., et al. Blood flow speed of the gastric conduit assessed by indocyanine green f luorescence : new predictive evaluation of anastomotic leakage after esophagectomy. Medicine. 2016; 95 : e4386.; Watanabe J., Ota M., Suwa Y., Suzuki S., Suwa H., Momiyama M., et al. Evaluation of the intestinal blood flow near the rectosigmoid junction using the indocyanine green fluorescence method in a colorectal cancer surgery. Int J Colorectal Dis. 2015; 30 : 329–335.; Kin C., Vo H., Welton L., Welton M. Equivocal effect of intraoperative fluorescence angiography on colorectal anastomotic leaks. Dis Colon Rectum. 2015; 58 : 582–587.; Inoue Y., Arita J., Sakamoto T., Ono Y., Takahashi M., Takahashi Y., et al. Anatomical liver resections guided by 3-dimensional parenchymal staining using fusion indocyanine green fluorescence imaging. Ann Surg. 2015; 262 : 105–111.; Kawaguchi Y., Nomura Y., Nagai M., Koike D., Sakuraoka Y., Ishida T., et al. Liver transection using indocyanine green fluorescence imaging and hepatic vein clamping. Br J Surg. 2017; 104 : 898–906.; Котов С.В., Простомолотов А.О. Симптоматические лимфатические кисты после онкоурологических операций на органах малого таза и влияние их анатомической локализации на клиническую картину. Вестник урологии. 2020; 8 (4) : 72–79.; Hurle R., Naspro R. Pelvic lymphadenectomy during radical cystectomy : a review of the literature. Surg Oncol. 2010; 19 : 208–220.; Schaafsma B.E., Verbeek F.P., Elzevier H.W., Tummers Q.R., van der Vorst J.R., Frangioni J.V., et al. Optimization of sentinel lymph node mapping in bladder cancer using near-infrared fluorescence imaging. J Surg Oncol. 2014; 110 (7) : 845–850.; Manny T.B., Hemal A.K. Fluorescence-enhanced robotic radical cystectomy using unconjugated indocyanine green for pelvic lymphangiography, tumor marking, and mesenteric angiography : the initial clinical experience. Urology. 2014; 83 (4) : 824–829.; Patel M.N., Hemal A.K. Molecular Targeted Fluorescence-Guided Intraoperative Imaging of Bladder Cancer Nodal Drainage Using Indocyanine Green During Radical and Partial Cystectomy. Curr Urol Rep. 2016; 17 (10) : 74.; Roth B., Wissmeyer M.P., Zehnder P., Birkhäuser F.D., Thalmann G.N., Krause T.M. et al. A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder. Eur Urol. 2010 Feb; 57 (2) : 205–11. doi:10.1016/j.eururo.2009.10.026.; https://www.malignanttumors.org/jour/article/view/1100

Διαθεσιμότητα: https://www.malignanttumors.org/jour/article/view/1100
https://doi.org/10.18027/2224-5057-2023-13-1-17-23

Efficacy and safety of negative wound pressure in the treatment of surgical complications after radical cystectomy: a retrospective cohort study ; Эффективность и безопасность применения отрицательного раневого давления в лечении хирургических осложнений после радикальной цистэктомии: ретроспективное когортное исследование

Συγγραφείς: Berkut M.V., Belyaev A.M., Krotov N.F., Karaseva M.E., Nosov A.K.

Συνεισφορές: 1

Πηγή: Almanac of Clinical Medicine; Vol 51, No 7 (2023); 365-375 ; Альманах клинической медицины; Vol 51, No 7 (2023); 365-375 ; 2587-9294 ; 2072-0505

Θεματικοί όροι: radical cystectomy, postoperative complications, peritonitis, negative pressure wound therapy, open abdomen, laparostomy, радикальная цистэктомия, послеоперационные осложнения, перитонит, вакуумная терапия ран, открытый живот, лапаростомия

Περιγραφή αρχείου: application/pdf

Relation: https://almclinmed.ru/jour/article/view/17166/1623; https://almclinmed.ru/jour/article/view/17166/1624; https://almclinmed.ru/jour/article/downloadSuppFile/17166/159719; https://almclinmed.ru/jour/article/downloadSuppFile/17166/159720; https://almclinmed.ru/jour/article/downloadSuppFile/17166/159721; https://almclinmed.ru/jour/article/downloadSuppFile/17166/159722; https://almclinmed.ru/jour/article/downloadSuppFile/17166/159723; https://almclinmed.ru/jour/article/downloadSuppFile/17166/159724; https://almclinmed.ru/jour/article/downloadSuppFile/17166/159725; https://almclinmed.ru/jour/article/downloadSuppFile/17166/159726; https://almclinmed.ru/jour/article/downloadSuppFile/17166/159727; https://almclinmed.ru/jour/article/downloadSuppFile/17166/159728; https://almclinmed.ru/jour/article/view/17166

Διαθεσιμότητα: https://almclinmed.ru/jour/article/view/17166
https://doi.org/10.18786/2072-0505-2023-51-039

The success of robot-assisted cystectomy in the treatment of muscle-invasive bladder cancer ; Успехи робот-ассистированной цистэктомии в лечении мышечно-инвазивного рака мочевого пузыря

Συγγραφείς: V. N. Pavlov, M. F. Urmantsev, M. R. Bakeev, В. Н. Павлов, М. Ф. Урманцев, М. Р. Бакеев

Πηγή: Cancer Urology; Том 18, № 2 (2022); 123-128 ; Онкоурология; Том 18, № 2 (2022); 123-128 ; 1996-1812 ; 1726-9776

Θεματικοί όροι: лапароскопическая радикальная цистэктомия, high-risk non-muscle-invasive bladder cancer, robot-assisted radical cystectomy, open radical cystectomy, laparoscopic radical cystectomy, немышечно-инвазивный рак мочевого пузыря высокого риска, робот-ассистированная радикальная цистэктомия, открытая радикальная цистэктомия

Περιγραφή αρχείου: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1476/1373; World Health Organization. International Agency for Research on Cancer. The Global Cancer Observatory (December, 2020). Bladder Source: Globocan 2020. Available at: https://gco.iarc.fr/today/data/factsheets/cancers/30-Bladder-fact-sheet.pdf.; Shabsigh A., Korets R., Vora K.C. et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009;55(1):164–74. DOI:10.1016/j.eururo.2008.07.031; Lowrance W.T., Rumohr J.A., Chang S.S. et al. Contemporary open radical cystectomy: analysis of perioperative outcomes. J Urol 2008;179(4):1313–8. DOI:10.1016/j.juro.2007.11.084; Ukimura O., Moinzadeh A., Gill I.S. Laparoscopic radical cystectomy and urinary diversion. Curr Urol Rep 2005;6(2):118–21. DOI:10.1007/s11934-005-0078-2; Bochner B.H., Sjoberg D.D., Laudone V.P. A randomized trial of robot-assisted laparoscopic radical cystectomy. N Engl J Med 2014;371(4):389–90. DOI:10.1056/NEJMc1405213; Khan M.S., Gan C., Ahmed K. et al. A Single-centre early phase randomised controlled three-arm trial of open, robotic, and laparoscopic radical cystectomy (CORAL). Eur Urol 2016;69(4):613–21. DOI:10.1016/j.eururo.2015.07.038; Novara G., Catto J.W., Wilson T. et al. Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. Eur Urol 2015;67(3):376–401. DOI:10.1016/j.eururo.2014.12.007; Гулиев Б.Г., Болокотов Р.Р. Сравнительный анализ результатов робот-ассистированной и открытой радикальной цистэктомии. Вестник урологии 2020; 8(1):59–68. DOI:10.21886/2308-6424-2020-8-1-59-68; Challacombe B.J., Bochner B.H., Dasgupta P. et al. The role of laparoscopic and robotic cystectomy in the management of muscle-invasive bladder cancer with special emphasis on cancer control and complications. Eur Urol 2011;60(4): 767–75. DOI:10.1016/j.eururo.2011.05.012; Gill I., Cacciamani G. The changing face of urologic oncologic surgery from 2000– 2018 (63141 patients) – impact of robotics. Eur Urol 2019;199:e656–7. DOI:10.1016/S1569-9056(19)30485-3; Mistretta F.A., Luzzago S., Musi G. et al. Minimally invasive versus open radical cystectomy: long term oncologic outcomes compared. Transl Androl Urol 2020;9(3):1006–8. DOI:10.21037/tau-2020-03; Feng D., Li A., Hu X. et al. Comparative effectiveness of open, laparoscopic and robot-assisted radical cystectomy for bladder cancer: a systematic review and network meta-analysis. Minerva Urol Nefrol 2020;72(3):251–64. DOI:10.23736/S0393-2249.20.03680-2; Fonseka T., Ahmed K., Froghi S. et al. Comparing robotic, laparoscopic and open cystectomy: a systematic review and meta-analysis. Arch Ital Urol Androl 2015;87(1):41–8. DOI:10.4081/aiua.2015.1.41; Khan M.S., Omar K., Ahmed K. et al. Long-term oncological outcomes from an early phase randomised controlled three-arm trial of open, robotic, and laparoscopic radical cystectomy (CORAL). Eur Urol 2020;77(1):110–8. DOI:10.1016/j.eururo.2019.10.027; Kim T.H., Sung H.H., Jeon H.G. et al. Oncological outcomes in patients treated with radical cystectomy for bladder cancer: comparison between open, laparoscopic, and robot-assisted approaches. J Endourol 2016;30(7):783–91. DOI:10.1089/end.2015.0652; https://oncourology.abvpress.ru/oncur/article/view/1476

Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/1476
https://doi.org/10.17650/1726-9776-2022-18-2-123-128

Neoadjuvant chemotherapy and radical cystectomy in patients with bladder cancer ; Неоадъювантная химиотерапия и радикальная цистэктомия у больных раком мочевого пузыря

Συγγραφείς: O. B. Karyakin, N. V. Vorobyov, I. N. Zaborskiy, A. G. Muradyan, K. N. Safiullin, I. A. Taraki, G. A. Demyashkin, S. A. Ivanov, A. D. Kaprin, О. Б. Карякин, Н. В. Воробьев, И. Н. Заборский, А. Г. Мурадян, К. Н. Сафиуллин, И. А. Тараки, Г. А. Демяшкин, С. А. Иванов, А. Д. Каприн

Συνεισφορές: The study was performed without external funding., Исследование проведено без спонсорской поддержки.

Πηγή: Cancer Urology; Том 18, № 3 (2022); 92-98 ; Онкоурология; Том 18, № 3 (2022); 92-98 ; 1996-1812 ; 1726-9776

Θεματικοί όροι: выживаемость, neoadjuvant chemotherapy, radical cystectomy, survival, неоадъювантная химиотерапия, радикальная цистэктомия

Περιγραφή αρχείου: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1568/1402; Состояние онкологической помощи населению России в 2020 году. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2021. 239 с.; Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2021. 252 с.; Antoni S., Ferlay J., Soerjomataram I. et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol 2017;71(1):96–108. DOI:10.1016/j.eururo.2016.06.010; Hamid A.R.A.H., Ridwan F.R., Parikesit D. et al. Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients. BMC Urol 2020;20(1):158. DOI:10.1186/s12894-020-00733-z; Mir M.C., Marchioni M., Zargar H. et al. Nomogram predicting bladder cancer-specific mortality after neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: results of an international consortium. Eur Urol Focus 2021;7(6):1347–54. DOI:10.1016/j.euf.2022.01.009; Narain T.A., Mohan Tosh J., Gautam G. et al. Neoadjuvant therapy for cisplatin ineligible muscle invasive bladder cancer patients: a review of available evidence. Urology 2021;154:8–15. DOI:10.1016/j.urology.2021.03.010; Лавникова Г.А. Гистологический метод количественной оценки терапевтического повреждения опухоли. М.: Методические рекомендации, 1979. 13 с.; Pfister C., Gravis G., Fléchon A. et al. Dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin or gemcitabine and cisplatin as perioperative chemotherapy for patients with nonmetastatic muscle-invasive bladder cancer: results of the GETUG-AFU V05 VESPER Trial. J Clin Oncol 2022;40(18):2013–22. DOI:10.1200/JCO.21.02051; Pfister C., Gravis G., Fléchon A. et al. Randomized phase III trial of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin, or gemcitabine and cisplatin as perioperative chemotherapy for patients with muscle-invasive bladder cancer. Analysis of the GETUG/AFU V05 VESPER trial secondary endpoints: chemotherapy toxicity and pathological responses. Eur Urol 2021;79(2):214–21. DOI:10.1016/j.eururo.2020.08.024; Гладков О.А., Зуков Р.А., Матвеев В.Б. и др. Практические рекомендации по лекарственному лечению рака мочевого пузыря. Злокачественные опухоли: Практические рекомендации RUSSCO 2021;11(3s2):523–9. DOI:10.18027/2224-5057-2021-11-3s2-32; https://oncourology.abvpress.ru/oncur/article/view/1568

Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/1568
https://doi.org/10.17650/1726-9776-2022-18-3-92-98

Bladder cancer: what's new in 2020-2021 ; Рак мочевого пузыря: что нового в 2020-2021 гг.

Συγγραφείς: O. B. Karyakin, О. Б. Карякин

Πηγή: Cancer Urology; Том 17, № 4 (2021); 115-123 ; Онкоурология; Том 17, № 4 (2021); 115-123 ; 1996-1812 ; 1726-9776

Θεματικοί όροι: рекомендация, genetic marker, radical cystectomy, follow-up, recommendation, генетический маркер, радикальная цистэктомия, динамическое наблюдение

Περιγραφή αρχείου: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1510/1324; EAU Guidelines. European Association of Urology, 2021.; Boormans J.L., De Jong J.J., Liu V.Y.T. et al. Luminal primary muscle-invasive bladder cancer patients are less likely to benefit from platinum-based neoadjuvant chemotherapy. Eur Urol 2021; 79(S 1):S1156.; Necchi A., DeJong J.J., Raggi D. Molecular characterization of residual bladder cancer after pembrolizumab. Eur Urol 2021;80(2):149-59. DOI:10.1016/j.eururo.2021.03.014.; De Wit R., Kulkarni G.S., Uchio E. et al. Pembrolizumab for high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG): phase II KEYNOTE-057 Trial. ESMO 2018. Abstr. 3575.; De Wit R., Kulkarni G.S., Uchio E. et al. Health-related quality of life (HRQoL) and updated follow-up from KEYNOTE-057: phase 2 study of pembrolizumab (pembro) for patients (pts) with high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG). ESMO 2019. Abstr. 2829.; Balar A.V., Kamat A.M., Kulkarni G.S. et al. Pembrolizumab for the treatment of patients with high-risk (HR) nonmuscle-invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin: extended follow-up of KEYNOTE-057 cohort A. ASCO GU 2021. Abstr. 451.; Flegar L., Baunacke M., Groeben C., Borkowetz A. Treatment trends for muscle-invasive bladder cancer in Germany from 2006 to 2018: Increasing case numbers facilitate more high-volume centers. Eur Urol 2021;79(S 1):S1148-50. DOI:10.1016/S0302-2838(21)01201-X.; Bajorin D.F., Witjes J.A., Gschwend J., Schenker M. First results from the phase 3 CheckMate 274 trial of adjuvant nivolumab vs placebo in patients who underwent radical surgery for high-risk muscle-invasive urothelial carcinoma (MIUC). J Clin Oncol 2021;39(6_suppl):391. DOI:10.1200/JCO.2021.39.6_suppl.391.; Van Hoogstraten L.M.C., Witjes J.A., Meijer R.P., Ripping T.M. Characteristics and survival of untreated versus treated patients with non-metastatic muscle invasive bladder cancer. Eur Urol 2021;79:S1166. DOI:10.1016/S0302-2838(21)01210-0.; Khanna A., Zganjar A., Paras Shah P. et al. Is there value to routine oncologic surveillance after radical cystectomy? Comparative outcomes of symptomatic versus asymptomatic recurrence. J Clin Oncol 2021;39(6_suppl):421. DOI:10.1200/JCO.2021.39.6_suppl.421.; Tural D., Olmez O.F., Sumbul A.T. et al. Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma. J Clin Oncol 2021;39(6_suppl):409. DOI:10.1200/JCO.2021.39.6_suppl.409.; Powles Т., Rosenberg J.E., Sonpavde G. et al. Primary results of EV-301: A phase III trial of enfortumab vedotin versus chemotherapy in patients with previously treated locally advanced or metastatic urothelial carcinoma. J Clin Oncol 2021;39(6_suppl):393. DOI:10.1200/JCO.2021.39.6_suppl.393.; Viswambaram P., Moe A., Chien Hern Liow E., Redfern A.D. Sub-urothelial durvalumab injection-1 (SUBDUE-1): a novel approach to immunotherapy for bladder cancer. J Clin Oncol 2021; 39(6_suppl):TPS503. DOI: /10.1200/JCO.2021.39.6_suppl. TPS503.; Powles T., Meeks J.J., Galsky M.D., van der Heijden M. A phase III, randomized, open-label, multicenter, global study of efficacy and safety of durvalumab in combination with gemcitabine plus cisplatin for neoadjuvant treatment followed by durvalumab alone for adjuvant treatment in muscle-invasive bladder cancer (NIAGARA). J Clin Oncol 2021;39(6_suppl):TPS505. DOI:10.1200/JCO.2021.39.6_suppl.TPS505.; Catto J.W.F., Downing А., Mason S. et al. Quality of life after bladder cancer: a cross-sectional survey of patient-reported outcomes. Eur Urol 2021;79(5):621-32. DOI:10.1016/j.eururo.2021.01.032.; Wallis C.J.D., Catto J.W.F., Finelli A. et al. The Impact of the COVID-19 pandemic on genitourinary cancer care: re-envisioning the future. Eur Urol 2020;78(5):731-42. DOI:10.1016/j.eururo.2020.08.030.; https://oncourology.abvpress.ru/oncur/article/view/1510

Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/1510
https://doi.org/10.17650/1726-9776-2021-17-4-115-123

The probability of developing a tumor in the small intestine neocyst ; Вероятность развития опухоли в тонкокишечном неоцисте

Συγγραφείς: A. A. Kеln, G. S. Petrosyan, A. V. Kupchin, A. V. Lykov, A. V. Lebedev, L. V. Volynkina, А. А. Кельн, Г. С. Петросян, А. В. Купчин, А. В. Лыков, А. В. Лебедев, Л. В. Волынкина

Συνεισφορές: The work was performed without external funding., Работа выполнена без спонсорской поддержки.

Πηγή: Cancer Urology; Том 18, № 3 (2022); 128-134 ; Онкоурология; Том 18, № 3 (2022); 128-134 ; 1996-1812 ; 1726-9776

Θεματικοί όροι: аденокарцинома неоциста, radical cystectomy, ileocystoplasty, neocyst adenocarcinoma, радикальная цистэктомия, илеоцистопластика

Περιγραφή αρχείου: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1525/1406; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1525/1077; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1525/1078; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1525/1079; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1525/1080; https://oncourology.abvpress.ru/oncur/article/downloadSuppFile/1525/1081; Чемакина А.А., Кельн А.А. Эпидемиология рака мочевого пузыря в Тюменской области за период 2008–2018 гг. Академический журнал Западной Сибири 2020;16(2):39–43.; Jaske G., Algaba F., Fossa S. et al. Recommendations from EAU Working Party on Muscle-Invasive and Metastatic Bladder cancer. Pocket Guidelines European Association of Urology, 2007. Pp. 19–20.; Pejcic T., Hadzi-Djokic J., Acimovic M. et al. Local recurrence of bladder cancer after cystectomy with orthotopic bladder substitution and ileal conduit. Acta Chir Iugosl 2007;54(4):63–7. DOI:10.2298/aci0704063p; Berberian G., Goeman L., Allory Y. et al. Adenocarcinoma of ileal neobladder 20 years after cystectomy. Urology 2006;68(6):1343e9–10. DOI:10.1016/j.urology.2006.09.014; Moore C.D., Iczkowski K.A., Blue K.M., Algood C.B. Urothelial carcinoma recurrence in ileal orthotopic neobladder: urethrectomy and creation of ileal conduit. Urology 2007;69(1):11–3. DOI:10.1016/j.urology.2006.10.013; Hautmann R.E., Volkmer B.G., Schumacher M.C. et al. Long-term results of standard procedures in urology: the ileal neobladder. World J Urol 2006;24(3):305–14. DOI:10.1007/s00345-006-0105-z; Oberneder R., Staudte S., Waidelich R. et al. Local recurrence in patients after radical cystectomy and orthotopic ileal neobladder: impact on function. Int Urol Nephrol 2003;35(2):175–9. DOI:10.1023/b:urol.0000020303.37190.95; Yossepowitch O., Dalbagni G., Golijanin D. et al. Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. J Urol 2003;169(1):177–81. DOI:10.1097/01.ju.0000041411.03266.14; Austen M., Kälble T. Secondary malignancies in different forms of urinary diversion using isolated gut. J Urol 2004;172(3):831–8. DOI:10.1097/01.ju.0000134890.07434.8e; Senkul T., Yildirim S., Işeri C. et al. Histopathologic changes in the mucosa of ileal orthotopic neobladder – findings in 24 patients followed up for 5 years. Scand J Urol Nephrol 2003;37(3):35–9. DOI:10.1080/00365590310008046; Aragona F., de Caro R., Parenti A. et al. Structural and ultrastructural changes in ileal neobladder mucosa: a 7-year follow-up. Br J Urol 1998;81(1):55–61. DOI:10.1046/j.1464-410x.1998.00514.x; Miyake H., Eto H., Takechi Y. et al. Increased urinary 8-hydroxy2’-deoxyguanosine excretion after ileal neobladder replacement. BJU Int 2003;91(7):657–60. DOI:10.1046/j.1464-410x.2003.04176.x; https://oncourology.abvpress.ru/oncur/article/view/1525

Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/1525
https://doi.org/10.17650/1726-9776-2022-18-3-128-134

Robot-Assisted and Open Radical Cystectomy: Comparative Analysis of Results ; Сравнительный анализ результатов робот-ассистированной и открытой радикальной цистэктомии

Συγγραφείς: B. G. Guliev, R. R. Bolokotov, Б. Г. Гулиев, Р. Р. Болотоков

Πηγή: Urology Herald; Том 8, № 1 (2020); 59-68 ; Вестник урологии; Том 8, № 1 (2020); 59-68 ; 2308-6424 ; 10.21886/2308-6424-2020-8-1

Θεματικοί όροι: робот-ассистированная радикальная цистэктомия, radical cystectomy, robot-assisted radical cystectomy, open radical cystectomy, радикальная цистэктомия, открытая радикальная цистэктомия

Περιγραφή αρχείου: application/pdf

Relation: https://www.urovest.ru/jour/article/view/306/236; Witjes JA, Compérat E, Cowan NC, De Santis M, Gakis G, Lebret T. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65:778–792.; https://doi.org/10.1016/j.eururo.2013.11.046 2. Leow JJ, Bedke J, Chamie K, Collins JW, Daneshmand S, Grivas P, Heidenreich A, Messing EM, Royce TJ, Sankin AI, Schoenberg MP, Shipley WU, Villers A, Efstathiou JA, Bellmunt J, Stenzl A. SIU-ICUD consulation on bladder cancer: treatment of muscle-invasive bladder cancer. World J. Urol. 2019; 37(1);61–83. https://doi.org/10.1007/s00345-018-2606-y; Shabsigh A, Korets R, Vora KC, Brooks CM, Cronin AM, Savage C, Raj G, Bochner BH, Dalbagni G, Herr HW, Donat SM. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol. 2009;55:164–174. https://doi.org/10.1016/j.eururo.2008.07.031; Hu JC, Chughtai B, O’Malley P, Halpern JA, Mao J, Scherr DS, Hershman DL, Wright JD, Sedrakyan A. Perioperative outcomes, health care costs and survival after robotic-assisted versus open radical cystectomy: a national comparative effectiveness study. Eur Urol. 2016;70:195–202. https://doi.org/10.1016/j.eururo.2016.03.028; Zamboni S, Soria F, Mathieu R, Xylinas E, Abufaraj M, Andrea D et al. Differences in trends in the use of robot-assisted and open radical cystectomy and changes over tine in peri-operative outcomes among selected centres in North America and Europe: an international multicentre collaboration. BJU Int. 2019; May 4. https://doi.org/10.1111/bju.14791 [Epub ahead of print]; Satkunasivam R, Wallis CJ, Nam R, Desai M, Gill I. Contemporary evidence for robot-assisted radical cystectomy for treating bladder cancer. Nat Rev Urol. 2016;13:533–539. https://doi.org/10.1038/nrurol.2016.139; Nix J, Smith A, Kurpad R, Nielsen ME, Wallen EM, Pruthi RS. Prospective randomized trial of robotic versus open radical cystectomy for bladder cancer; peri-operative and pathologic results. Eur Urol. 2010;57:196–201. https://doi.org/10.1016/j.eururo.2009.10.024; Parekh DJ, Messer J, Fitzgerald J, Ercole B, Svatek R. Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robot ic assisted radical cystectomy. J Urol. 2013;189:474–479. https://doi.org/10.1016/j.juro.2012.09.077; Bochner BH, Dalbagni G, Sjoberg DD, Silberstein J, Keren Paz SM, Donat SM et al. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur Urol. 2015;67:1042–1050. https://doi.org/10.1016/j.eururo.2014.11.043; Khan MS, Gan C, Ahmed K, Ahmad FI, Watkins J, Summers JA et al. A single-centre early phase randomized controlled three- arm trial of open, robotic and laparoscopic radical cystectomy (CORAL). Eur Urol. 2016;69:613–621. https://doi.org/10.1016/j.eururo.2015.07.038; Li K, Lin T, Fan X, Xu K, Bi L, Duan Y et al. Systematic review and met-analysis of comparative studies reporting early outcomes after robot-assisted cystectomy versus open radical cystectomy. Cancer Treat Rev 2013;39:551–560.; Novara G, Catto JW, Wilson T, Annerstedt M, Chan K, Murphy DG et al. Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. Eur Urol. 2015;67:376‒401. https://doi.org/10.1016/j.eururo.2014.12.007; Yuh B, Wilson T, Bochner B, Chan K, Palou J, Stenzl A et al. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. Eur Urol. 2015;67:402‒422. https://doi.org/10.1016/j.eururo.2014.12.008; Shen Zh, Sun Zh. Systematic review and meta-analysis of randomised trials of perioperative outcomes comparing robot-assisted versus open radical cystectomy. BMC Urol. 2016;16:59–67. https://doi.org/10.1186/s12894-016-0177-z; Sathianathen NJ, Kalapara A, Frydenberg M, Lawrentschuk N, Weight CJ, Parekh D, Konety BR. Robotic assisted radical cystectomy vs open radical cystecyomy: systematuc review and meta-analysis. J. Urol. 2019;201:715–720. https://doi.org/10.1016/j.juro.2018.10.006; Kimura S, Iwata T, Foerster B, Fossati N, Brigabti A. Nasu Y et al. Comparison of perioperative complications and healthrelated quality of life between robot-assisted and radical cystectomy: a systematic review and meta-analysis. Int J Urol. 2019;26:760–774. https://doi.org/10.1111/iju.14005; Albisini S, Veccia A, Aoun F, Diamand R, Esperto F et al. A systematic review and meta-analysis comparing the outcomes of open and robotic assisted radical cystectomy. Minerva Urol Nephrol. 2019; 71(6):553–568. https://doi.org/10.23736/S0393-2249.19.03546-X; Iwata T, Kimura S, Foerster B, Fossati N, Briganti A et al. Oncologic outcomes after robot-assisted versus open radical cystectomy; a systematic review and meta-analysis. World J. Urol. 2019;37(8):1557–1570. https://doi.org/10.1007/s00345-019-02708-8; Yu HY, Hevelone ND, Lipsitz SR, Kowalczyk KJ, Nguyen PL, Choueiri TK et al. Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. Eur Urol. 2012;61:1239‒1244. https://doi.org/10.1016/j.eururo.2012.03.032; Wijburg CJ, Michels CT, Oddens JR, Grutters JP, Witjes JA, Rovers MM. Robot-assisted radical cystectomy versus open radical cystectomy in bladder cancer (RACE): study protocol of a non-randomized comparative effectiveness study. BMC Cancer. 2018;18:861. https://doi.org/10.1186/s12885-018-4779-6; Hayn MN, Hussain A, Mansour AM et al. The learning curve of robot-assisted radical cystectomy: resuts from the international robotic cystectomy consortium. Eur Urol. 2010;58:197–201. https://doi.org/10.1016/j.eururo.2010.04.024; Honore M, Roberts MJ, Morton A, Teloken PE, Navaratnam A, Coughlin GD. Outcomes and learning curve for roboticassisted radical cystectomy: an Australian experience. ANZ J. Surg. 2019; Sep 2. https://doi.org/10.1111/ans.15413 [Epub ahead of print]; Khan MS, Challacombe B, Elhage O, Rimington P, Coker B, Murphy D et al. A dual-centre, cohort comparison of open, laparoscopic, and robotic-assisted radical cystectomy. Int J Clin Pract. 2012;66:656–662.; Parekh D, Gables C. A prospective multicenter randomized trial of open versus robotic radical cystectomy (RAZOR). J Urol. 2017;197:e918.; Styn NR, Montgomery JS, Wood DP, Hafez KS, Lee CT, Tallman C et al. Matched comparison of robotic-assisted and open radical cystectomy. Urology. 2012;79:1303‒1308. https://doi.org/10.1016/j.urology.2012.01.055; Ng CK, Kauffman EC, Lee MM, Otto BJ, Portnoff A, Ehrlich JR et al. A comparison of postoperative complications in open versus robotic cystectomy. Eur Urol. 2010;57:274‒281. https://doi.org/10.1016/j.eururo.2009.06.001; Leow JJ, Reese SW, Jiang W, Lipsitz SR, Bellmunt J, Trinh QD et al. Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population-based analysis in the United States. Eur Urol. 2014; 66:569‒576. https://doi.org/10.1016/j.eururo.2014.01.029; Smith A, Kurpad R, Lal A, Nielsen M, Wallen EM, Pruthi RS. Cost analysis of robotic versus open radical cystectomy for bladder cancer. J Urol. 2010;183:505‒509. https://doi.org/10.1016/j.juro.2009.09.081; Lee R, Chughtai B, Herman M, Shariat SF, Scherr DS. Costanalysis comparison of robot-assisted laparoscopic radical cystectomy (RC) vs open RC. BJU Int. 2011;108:976–983. https://doi.org/10.1111/j.1464-410X.2011.10468.x; Knox ML, El-Galley R, Busby JE. Robotic versus open radical cystectomy: identification of patients who benefit from the robotic approach. J. Endourol. 2013;27(1):40–44. https://doi.org/10.1089/end.2012.0168; Aboumohamed AA Raza SJ, Al-Daghmin A, Tallman C, Creighton T, Crossley H et al. Health-related quality of life outcomes after robot-assisted and open radical cystectomy using a validated bladder-specific instrument: a multi-institutional study. J Urol. 2014;83:1300–1308. https://doi.org/10.1016/j.urology.2014.02.024; Messer JC, Punnen S, Fitzgerld J, Svatek R, Parekh DJ. Healthrelated quality of life from a prospective randomized clinical trial of robot-assisted laparoscopic versus open radical cystectomy. BJU Int. 2014;114: 896–902. https://doi.org/10.1111/bju.12818; Satkunasivam R, Santomauro M, Chopra S, Plotner E, Cai J, Miranda G et al. Robotic intracorporeal orthotopic neobladder: urodynamic outcomes, urinary function, and healthrelated quality of life. Eur Urol. 2016;69:247‒253. https://doi.org/10.1016/j.eururo.2015.06.041; Steers WD. Voiding dysfunction in the orthotopic neobladder. World J Urol. 2000;18:330‒337. PMID: 11131310; Steven K, Poulsen AL. The orthotopic Kock ileal neobladder: functional results, urodynamic features, complications and survival in 166 men. J Urol. 2000;164:288‒295. PMID: 10893568; Tyritzis SI, Hosseini A, Collins J, Nyberg T, Jonsson MN, Laurin O et al. Oncologic, functional, and complications outcomes of robot-assisted radical cystectomy with totally intracorporeal neobladder diversion. Eur Urol. 2013;64:734‒741.; Canda AE, Atmaca AF, Altinova S, Akbulut Z, Balbay MD. Robot- assisted nerve-sparing radical cystectomy with bilateral extended pelvic lymph node dissection (PLND) and intracor poreal urinary diversion for bladder cancer: initial experience in 27 cases. BJU Int. 2012;110:434‒444.; Stein JP, Lieskovsky G, Cote R, Groshen S, Feng AC, Boyd S et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666–675.; Raza SJ, Wilson T, Peabody JO, Wiklund P, Scher DS, Al-Daghmin A et al. Long-term oncologic outcomes following robotassisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol. 2015;68:721–728. https://doi.org/10.1016/j.eururo.2015.04.021; Ghoneim MA, Abdel-Latif M, el-Mekresh M. Radical cystectomy for carcinoma of the bladder: 2720 consecutive cases 5 years later. J Urol. 2008;180:121–127. https://doi.org/10.1016/j.juro.2016.12.048; Hautmann RE, dePetriconi RC, Pfeiffer C, Volkmer BG. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol. 2012;61:1039–1047. https://doi.org/10.1016/j.eururo.2012.02.028; Patel R, Szymaniak J, Radadia K, Faiena I, Lasser M. Controversies in robotics: open versus robotic radical cystectomy. Clin Genitourin Cancer. 2015;13:421‒427. https://doi.org/10.1016/j.clgc.2015.06.006; Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M et al. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. J Urol. 2007;178: 2308‒2312. PMID: 17936804; Novara G, Svatek RS, Karakiewicz PI, Skinner E, Ficarra V, Fradet Y et al. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol. 2010;183:2165‒2170. https://doi.org/10.1016/j.juro.2010.02.021; Nguyen DP, Al Hussein Al Awamlh B, Wu X, O’Malley P, Inoyatov IM, Ayangbesan A, Faltas BM, Christos PJ, Scherr DS. Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer. Eur Urol. 2015;68(3):399‒405. https://doi.org/10.1016/j.eururo.2015.02.003; Skinner DG. Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference. J Urol. 1982;128:34‒36.; Wright JL, Lin DW, Porter MP. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy. Cancer. 2008;112:2401‒2408. https://doi.org/10.1002/cncr.23474; Karl A, Carroll PR, Gschwend JE, Knuchel R, Montorsi F, Stief CG et al. The impact of lymphadenectomy and lymph node metastasis on the outcomes of radical cystectomy for bladder cancer. Eur Urol. 2009;55:826‒835. https://doi.org/10.1016/j.eururo.2009.01.004; Abaza R, Dangle PP, Gong MC, Bahnson RR, Pohar KS. Quality of lymphadenectomy is equivalent with robotic and open cystectomy using an extended template. J Urol. 2012;187:1200‒1204. https://doi.org/10.1016/j.juro.2011.11.092; Hussein AA, Elsayed AS, Aldhaam NA, Jing Zh, Osei J et al. Ten-year oncologic outcomes following robot-assisted radical cystectomy: results from the International robotic cystectomy consortium. J. Urol. 2019;202:927–935. https://doi.org/10.1097/JU.0000000000000386; Venkatramani V, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS et al. Predictors of Recurrence, and Progression- Free and Overall Survival following Open versus Robotic Radical Cystectomy: Analysis from the RAZOR Trial with a 3-Year Followup. J Urol. 2020;203(3):522‒529. https://doi.org/10.1097/JU.0000000000000565; Faraj KS, Abdul-Muhsin HM, Rose KM, Navaratnam AK, Patton MW, Eversman S et al. Robot-assisted radical cystectomy vs open radical cystectomy: Over 10 years of the Mayo Clinic experience. Urol. Oncol. 2019;37(12):862‒869. https://doi.org/10.1016/j.urolonc.2019.07.019; Nieuwenhuijzen JA, de Vries RR, van Tinterern H, Bex A, Van der Poel HG, Meinhardt W et al. Follow-up after cystectomy: regularly scheduled, risk adjusted or symptom guided? Patterns of recurrence, relapse presentation and survival after cystectomy. Eur J Surg Oncol. 2014;40:1677–1685. https://doi.org/10.1016/j.ejso.2013.12.017; Wei L, Hussein AA, Ma Y, Azabdaftari G, Ahmed Y et al. Accurate quantification of residual cancer cells in pelvic washing reveals association with cancer recurrence following robotassisted radical cystectomy. J. Urol. 2019;201(6):1105–1114. https://doi.org/10.1097/JU.0000000000000142; Collins JW, Hosseini A, Adding C, Nyberg T, Koupparis A, Rowe E et al. Early Recurrence Patterns following totally intracorporeal robot-assisted radical cystectomy: results from the EAU Robotic Urology Section (ERUS) Scientific Working Group. Eur Urol. 2017;71:723–726. https://doi.org/10.1016/j.eururo.2016.10.030; https://www.urovest.ru/jour/article/view/306

Διαθεσιμότητα: https://www.urovest.ru/jour/article/view/306
https://doi.org/10.21886/2308-6424-2020-8-1-59-68

Robot-assisted radical cystectomy with urinary intestinal diversion (literature review) ; Робот-ассистированная радикальная цистэктомия с кишечной деривацией мочи (обзор литературы)

Συγγραφείς: B. G. Gulie, R. R. Bolokotov, Б. Г. Гулиев, Р. Р. Болотоков

Συνεισφορές: Без спонсорской помощи

Πηγή: Cancer Urology; Том 16, № 2 (2020); 135-143 ; Онкоурология; Том 16, № 2 (2020); 135-143 ; 1996-1812 ; 1726-9776 ; 10.17650/1726-9776-2020-16-2

Θεματικοί όροι: робот-ассистированная радикальная цистэктомия, radical cystectomy, open radical cystectomy, robot-assisted radical cystectomy, радикальная цистэктомия, открытая радикальная цистэктомия

Περιγραφή αρχείου: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1000/1162; Witjes J.A., Comperat E., Cowan N.C. et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol 2014;65:778-92. DOI:10.1016/j.eururo.2013.11.046.; Leow J.J., Bedke J., Chamie K. et al. SIU-ICUD consulation on bladder cancer: treatment of muscle-invasive bladder cancer. World J Urol 2019;37(1):61—83. DOI:10.1007/s00345-018-2606-y.; Sanchez de Badajoz E., Gallego Perales J.L., Reche Rosado A. et al. Laparoscopic cystectomy and ileal conduit: case report. J Endourol 1995;9:59-62. DOI:10.1089/end.1995.9.59.; Gill I.S., Fergany A., Klein E.A. et al. Laparoscopic radical cystoprostatectomy with ileal conduit performed completely intracorporeally: the initial 2 cases. Urology 2000;56:26-9. DOI:10.1016/s0090-4295(00)00598-7.; Gill I.S., Kaouk J.H., Meraney A.M. et al. Laparoscopic radical cystectomy and continent orthotopic ileal neobladder performed completely intracorporeally: the initial experience. J Urol 2002;168:13-8. DOI:10.1097/00005392-200207000-00005.; Hemal A.K., Kolla S.B., Wadhwa P. et al. Laparoscopic radical cystectomy and extracorporeal urinary diversion: a single center experience of 48 cases with three years of follow-up. Urology 2008;71(1):41-6. DOI:10.1016/j.urology.2007.08.056.; Menon M., Hemal A.K., Tewari A. et al. Nerve-sparing robot-assisted radical cystoprostatectomy and urinary diversion. BJU Int 2003;92:232-6. DOI:10.1046/j.1464-410x.2003.04329.x.; Menon M., Hemal A.K., Tewari A. et al. Robot-assisted radical cystectomy and urinary diversion in female patients: technique with preservation of the uterus and vagina. J Am Coll Surg 2004;198(3):386-93. DOI:10.1016/j.jamcollsurg.2003.11.010.; Zehnder P., Gill I.S. Cost-effectiveness of open versus laparoscopic versus robotic-assisted laparoscopic cystectomy and urinary diversion. Curr Opin Urol 2011;21:415-9. DOI:10.1097/MOU.0b013e3283490582.; Woods M.E., Wiklund P., Castle E.K. Robot-assisted radical cystectomy: recent advances and review of the literature. Curr Opin Urol 2010;20(2):125—9. DOI:10.1097/MOU.0b013e328336258f.; Raza S.J., Tawfeeq M., Al-Daghmin A., Guru K.A. Robot-assisted intracorporeal urinary diversion: where do we stand in 2014? Urol Clin North Am 2014;41(4):503-9. DOI:10.1016/j.ucl.2014.07.005.; Collins J.W., Wiklund N.P. Totally intracorporeal robot-assisted radical cystectomy: optimizing total outcomes. BJU Int 2014;114(3):326—33. DOI:10.1111/bju.12558.; Smith A., Kurpad R., Lal A. et al. Cost analysis of robotic versus open radical cystectomy for bladder cancer. J Urol 2010;183(2):505-9. DOI:10.1016/j.juro.2009.09.081.; Pruthi R.S., Wallen E.M. Robotic-assisted laparoscopic radical cystoprostatectomy. Eur Urol 2008;53(2):310—22. DOI:10.1016/j.eururo.2007.03.067.; Wang G.J., Barocas D.A., Raman J.D., Scherr D.S. Robotic vi open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy. BJU Int 2008;101(1):89—93. DOI:10.1111/j.1464-410X.2007.07212.x.; Nix J., Smith A., Kurpad R. et al. Prospective randomized controlled trial of robotic versus open radical cystectomy for bladder cancer: perioperative and pathologic results. Eur Urol 2010;57(2):196—201. DOI:10.1016/j.eururo.2009.10.024.; Martin A.D., Nunez R.N., Castle E.P. Robot-assisted radical cystectomy versus open radical cystectomy: a complete cost analysis. Urology 2011;77(3):621—5. DOI:10.1016/j.urology.2010.07.502.; Li K., Lin T., Fan X. et al. Systematic review and meta-analysis of comparative studies reporting early outcomes after robot-assisted radical cystectomy versus open radical cystectomy. Cancer Treat Rev 2013;39(6):551—60. DOI:10.1016/j.ctrv.2012.11.007.; Parekh D.J., Messer J., Fitzgerald J. et al. Perioperative outcomes and oncologic efficacy from a pilot prospective randomized clinical trial of open versus robotic assisted radical cystectomy. J Urol 2013;189(2):474—9. DOI:10.1016/j.juro.2012.09.077.; Bochner B.H., Dalbagni G., Sjoberg D.D. et al. Comparing open radical cystectomy and robot-assisted laparoscopic radical cystectomy: a randomized clinical trial. Eur Urol 2015;67(6):1042— 50. DOI:10.1016/j.eururo.2014.11.043.; Khan M.S., Gan C., Ahmed K. et al. A single-centre early phase randomised controlled three-arm trial of open, robotic and laparoscopic radical cystectomy (CORAL). Eur Urol 2016;69(4):613-21. DOI:10.1016/j.juro.2015.07.038.; Yuh B., Wilson T., Bochner B. et al. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy. Eur Urol 2015;67(3):402-22. DOI:10.1016/j.eururo.2014.12.008.; Raza S.J., Wilson T., Peabody J.O. et al. Long-term oncologic outcomes following robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol 2015;68(4):721—8. DOI:10.1016/j.eururo.2015.04.021.; Stein J.P., Lieskovsky G., Cote R. et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001;19(3):666—75. DOI:10.1200/JCO.2001.19.3.666.; Ghoneim M.A., Abdel-Latif M., El-Me-kresh M. Radical cystectomy for carcinoma of the bladder: 2720 consecutive cases 5 years later. J Urol 2008;180(1):121-7. DOI:10.1016/j.juro.2008.03.024.; Hautmann R.E., de Petriconi R.C., Pfeiffer C., Volkmer B.G. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients. Eur Urol 2012;61(5):1039—47. DOI:10.1016/j.eururo.2012.02.028.; Collins J.W., Tyritzis S., Nyberg T. et al. Robot-assisted radical cystectomy: description of an evolved approach to radical cystectomy. Eur Urol 2013;64(4):654 -63. DOI:10.1016/j.eururo.2013.05.020.; Novara G., Svatek R.S., Karakiewicz P.I. et al. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients. J Urol 2010;183(6):2165—70. DOI:10.1016/j.uro.2010.02.021.; Novara G., Catto J.W., Wilson T. et al. Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy. Eur Urol 2015;67(3):376—401. DOI:10.1016/j.eururo.2014.12.007.; Snow-Lisy D.C., Campbell S.C., Gill I.S. et al. Robotic and laparoscopic radical cystectomy for bladder cancer: long-term oncologic outcomes. Eur Urol 2014;65(1):193—200. DOI:10.1016/j.eururo.2013.08.021.; Nguyen D.P., Al Hussein Al Awamlh B., Wu X. et al. Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer. Eur Urol 2015;68(3):399—405. DOI:10.1016/j.eururo.2015.02.003.; Smith N.D., Castle E.P., Gonzalgo M.L. et al. The RAZOR (randomized open vi robotic cystectomy) trial: study design and trial update. BJU Int 2015;115(2): 198-205. DOI:10.1111/bju.12699.; Parekh D.J., Reis I.M., Casltle E.P. et al. Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomized, phase 3, non-inferioty trial. Lancet 2018;391(10139):2525-36. DOI:10.1016/S0140-6736(18)30996-6.; Venkatramani V., Reis I.M., Castle E.P. et al. Predictors of recurrence, progression-free and overall survival following open versus robotic radical cystectomy: analysis from the RAZOR trial with a 3-year follow up. J Urol 2020;203(3):522-9. DOI:10.1097/JU.0000000000000565.; Faraj K.S., Abdul-Muhsin H.M., Rose K.M. et al. Robot-assisted radical cystectomy vs open radical cystectomy: over 10 years of the Mayo Clinic experience. Urol Oncol 2019;37(12):862-9. DOI:10.1016/j.urolonc.2019.07.019.; Hussein A.A., Elsayed A.S., Aldhaam N.A. et al. Ten-year oncologic outcomes following robot-assisted radical cystectomy: results from the International robotic cystectomy consortium. J Urol 2019;202(5):927—35. DOI:10.1097/JU.0000000000000386.; Richards K.A., Kader K., Pettus J.A. et al. Does initial learning curve compromise outcomes for robot-assisted radical cystectomy? A critical evaluation of the first 60 cases while establishing a robotics program. J Endourol 2011;25(9):1553—8. DOI:10.1089/end.2010.0630.; Sharma N.L., Papadopoulos A., Lee D. et al. First 500 cases of robotic-assisted laparoscopic radical prostatectomy from a single UK centre: learning curves of two surgeons. BJU Int 2011;108(5):739—47. DOI:10.1111/j.1464-410X.2010.09941.x.; Hayn M.H., Hellenthal N.J., Hussain A. et al. Does previous robot-assisted radical prostatectomy experience affect outcomes at robot-assisted radical cystectomy? Results from the International Robotic Cystectomy Consortium. Urology 2010;76(5):1111—6. DOI:10.1016/j.urology.2010.05.010.; Desai M.M., Gill I.S., de Castro Abreu A.L. et al. Robotic intracorporeal orthotopic neobladder during radical cystectomy in 132 patients. J Urol 2014;192(6):1734—40. DOI:10.1016/j.uro.2014.06.087.; Honore M., Roberts M.J., Morton A. et al. Outcomes and learning curve for robot-assisted radical cystectomy: an Austrian experience. ANZ J Surg 2019;89(12):1593—8. DOI:10.1111/ans.15413.; Shabsigh A., Korets R., Vora K.C. et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009;55(1):164—74. DOI:10.1016/j.eururo.2008.07.031.; Novara G., de Marco V., Aragona M. et al. Complications and mortality after radical cystectomy for bladder transitional cell cancer. J Urol 2009;182(3):914—21. DOI:10.1016/j.uro.2009.05.032.; Chan K.G., Collins J.W., Wiklund N.P. Robot-assisted radical cystectomy: extracorporeal vs intracorporeal urinary diversion. J Urol 2015;193(5):1467—9. DOI:10.1016/j.uro.2015.02.042.; Ahmed K., Khan S.A., Hayn M.H. et al. Analysis of intracorporeal compared with extracorporeal urinary diversion after robot-assisted radical cystectomy: results from the International Robotic Cystectomy Consortium. Eur Urol 2014;65(2):340—7. DOI:10.1016/j.eururo.2013.09.042.; Anderson C.B., Morgan T.M., Kappa S. et al. Ureteroenteric anastomotic strictures after radical cystectomy — does operative approach matter? J Urol 2013;189(2):541—7. DOI:10.1016/j.uro.2013.02.022.; Abreu A.L., Chopra S., Azhar R.A. et al. Robotic radical cystectomy and intracorporeal urinary diversion: the USC technique. Indian J Urol 2014;30(3):300—6. DOI:10.4103/0970-1591.; Tyritzis S.I., Hosseini A., Collins J. et al. Oncologic, functional, and complications outcomes of robot-assisted radical cystectomy with totally intracorporeal neobladder diversion. Eur Urol 2013;64(5):734—41. DOI:10.1016/j.eururo.2013.05.050.; Azzouni F.S., Din R., Rehman S. et al. The first 100 consecutive, robot-assisted, intracorporeal ileal conduits: evolution of technique and 90-day outcomes. Eur Urol 2013;63(4):637—43. DOI:10.1016/j.eururo.2012.11.055.; Koupparis A., Villeda-Sandoval C., Weale N. et al. Robot-assisted radical cystectomy with intracorporeal urinary diversion: impact on an established enhanced recovery protocol. BJU Int 2015;116(6):924—31. DOI:10.1111/bju.13171.; Pyun J.H., Kim H.K., Cho S. et al. Robot-assisted radical cystectomy with total intracorporeal urinary diversion: comparative analysis with extracorporeal urinary diversion. J Laparoendosc Adv Surg Tech А 2016;26(5):349—55. DOI:10.1089/lap.2015.0543.; Ahmadi N., Ashrafi A.N., Hartman N. et al. Use of indocyanine green to minimize uretero-enteric strictures after robotic radical cystectomy. BJU Int 2019;124(2):302—7. DOI:10.1111/bju.14733.; Tan W.S., Lamb B.W., Tan M.Y. et al. In-depth critical analysis of complications following robot-assisted radical cystectomy with intracorporeal urinary diversion. Eur Urol Focus 2017;3(2—3):273—9. DOI:10.1016/j.euf.2016.06.002.; Studer U.E., Burkhard F.C., Schumacher M. et al. Twenty years experience with an ileal orthotopic low pressure bladder substitute — lessons to be learned. J Urol 2006;176(1):161 —6. DOI:10.1016/S0022-5347(06)00573-8.; Shah S.H., Movassaghi K., Skinner D. et al. Ureteroenteric strictures after open radical cystectomy and urinary diversion: the University of Southern California experience. Urology 2015;86(1):87—91. DOI:10.1016/j.urology.2015.03.014.; Ahmed Y.E., Hussein A.A., May P.R. et al. Natural history, predictors and management of ureteroenteric strictures after robot assisted radical cystectomy. J Urol 2017;198(3):567—74. DOI:10.1016/j.juro.2017.02.3339.; Rhee J.J., Lebeau S., Smolkin M., Theodorescu D. Radical cystectomy with ileal conduit diversion: early prospective evaluation of the impact of robotic assistance. BJU Int 2006;98(5):1059—63. DOI:10.1111/j.1464-410X.2006.06372.x.; Goh A.C., Gill I.S., Lee D.J. et al. Robotic intracorporeal orthotopic ileal neobladder: replicating open surgical principles. Eur Urol 2012;62(5):891 —901. DOI:10.1016/j.eururo.2012.07.052.; Pruthi R.S., Nix J., McRackan D. et al. Robotic-assisted laparoscopic intracorporeal urinary diversion. Eur Urol 2010;57(6):1013—21. DOI:10.1016/j.eururo.2009.12.028.; Guru K.A., Mansour A.M., Nyquist J. Robot-assisted intracorporeal ileal conduit “Marionette” technique. BJU Int 2010;106(9):1404—20. DOI:10.1111/j.1464-410X.2010.09772.x.; Schwentner C., Sim A., Balbay M.D. et al. Robot-assisted radical cystectomy and intracorporeal neobladder formation: on the way to a standardized procedure. World J Surg Oncol 2015;13(1):3. DOI:10.1186/1477-7819-13-3.; Simone G., Papalia R., Misuraca L. et al. Robotic intracorporeal Padua ileal bladder: surgical technique, perioperative, oncologic and functional outcomes. Eur Urol 2018;73(6):934—40. DOI:10.1016/j.eururo.2016.10.018.; Hussein A.A., Ahmed Y.E., Kozlowski J.D. et al. Robot-assisted approach to “W”-configuration urinary diversion: a step-by-step technique. BJU Int 2017;120(1):152—7. DOI:10.1111/bju.13824.; Jonsson M.N., Adding L.C., Hosseini A. et al. Robot-assisted radical cystectomy with intracorporeal urinary diversion in patients with transitional cell carcinoma of the bladder. Eur Urol 2011;60(5):1066—73. DOI:10.1016/j.eururo.2011.07.035.; Satkunasivam R., Santomauro M., Chopra S. et al. Robotic intracorporeal orthotopic neobladder: urodynamic outcomes, urinary function, and health-related quality of life. Eur Urol 2016;69(2):247—53. DOI:10.1016/j.eururo.2015.06.041.; Goh A.C., Aghazadeh M.A., Krasnow R.E. et al. Robotic intracorporeal continent cutaneous urinary diversion: primary description. J Endourol 2015;29(11):1217—20. DOI:10.1089/end.2014.0750.; Rowland R.G., Mitchell M.E., Bihrle R. et al. Indiana continent urinary reservoir. J Urol 1987;137(6):1136—9. DOI:10.1016/s0022-5347(17)44428-4.; Desai M.M., Simone G., de Castro Abreu A.L. et al. Robotic intracorporeal continent cutaneous diversion. J Urol 2017;198(2):436—44. DOI:10.1016/j.juro.2017.01.091.; Yu H.Y., Hevelone N.D., Lipsitz S.R. et al. Comparative analysis of outcomes and costs following open radical cystectomy versus robot-assisted laparoscopic radical cystectomy: results from the US Nationwide Inpatient Sample. Eur Urol 2012;61(6):1239—44. DOI:10.1016/j.eururo.2012.03.032.; Leow J.J., Reese S.W., Jiang W. et al. Propensity-matched comparison of morbidity and costs of open and robot-assisted radical cystectomies: a contemporary population — based analysis in the United States. Eur Urol 2014;66(3):569-76. DOI:10.1016/j.eururo.2014.01.029.; Lee R., Chughtai B., Herman M. et al. Cost-analysis comparison of robot-assisted laparoscopic radical cystectomy (RC) vs open RC. BJU Int 2011;108(6 Pt 2):976—83. DOI:10.1111/j.1464-410X.2011.10468.x.; https://oncourology.abvpress.ru/oncur/article/view/1000

Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/1000
https://doi.org/10.17650/1726-9776-2020-16-2-135-143

Analysis of the patients' quality of life after radical cystectomy with the orthotopic neobladder or ileal conduit formation ; Анализ качества жизни пациентов после радикальной цистэктомии с формированием ортотопического необладдера или илеокондуита

Συγγραφείς: S. V. Kotov, A. L. Khachatryan, D. P. Kotova, A. K. Zhuravleva, Sh. M. Sargsyan, D. M. Magomedov, С. В. Котов, А. Л. Хачатрян, Д. П. Котова, А. К. Журавлева, Ш. М. Саргсян, Д. М. Магомедов

Πηγή: Urology Herald; Том 9, № 1 (2021); 47-55 ; Вестник урологии; Том 9, № 1 (2021); 47-55 ; 2308-6424 ; 10.21886/2308-6424-2021-9-1

Θεματικοί όροι: осложнения после радикальной цистэктомии, radical cystectomy, quality of life after radical cystectomy, intestinal urine diversion, complications after radical cystectomy, радикальная цистэктомия, качество жизни после радикальной цистэктомии, кишечная деривация мочи

Περιγραφή αρχείου: application/pdf

Relation: https://www.urovest.ru/jour/article/view/413/300; Tyson MD 2nd, Barocas DA. Quality of Life After Radical Cystectomy. Urol Clin North Am. 2018;45(2):249-256. DOI:10.1016/j.ud.2017.12.008; Даренков С.П., Котов С.В., Проскоков А.А., Юсуфов А.Г., Беломытцев С.В., Бадовская Е.В., Губайдуллин Р.Р., Пинчук И.С. Значение программы «хирургия быстрого восстановления» в оперативном лечении опухолей мочевого пузыря. Урология. 2015;2:109-115. PMID: 28247690; Даренков С.П., Кривобородов Г.Г., Котов С.В., Дзитиев В.К., Проскоков А.А., Пинчук И.С. Осложнения радикальной цистэктомии с орто- и гетеротопической кишечной пластикой (обзор литературы). Вестник Российского государственного медицинского университета. 2013;4:49-53. eLIBRARY ID: 24286247; Васильев О.Н., Перепечай В.А., Рыжкин А.В. Ранние и поздние послеоперационные осложнения после радикальной цистэктомии при раке мочевого пузыря. Вестник урологии. 2019;7(2):24-50. DOI:10.21886/2308-6424-2019-7-2-24-50; Лоран О.Б., Серегин И.В., Хачатрян А.Л., Гуспанов Р.И. 10-летний опыт применения прямых уретероинтести-нальных анастомозов при кишечной деривации мочи после радикальной и простой цистэктомии. Урология. 2015;(4):48-51. PMID: 26665765; Котов С.В., Хачатрян А.Л., Гуспанов Р.И., Пульбере С.А., Беломытцев С.В., Юсуфов А.Г., Котова Д.П. Оценка частоты послеоперационных хирургических осложнений у пациентов, подвергшихся радикальной цистэктомии. Онкоурология. 2018;14(4):95-102. DOI:10.17650/1726-9776-2018-14-4-95-102; Носов А.К., Рева С.А., Джалилов И.Б., Петров С.Б. Радикальная цистэктомия при раке мочевого пузыря: сравнение ранних хирургических осложнений при лапароскопической, открытой и видеоассистированой операции. Онкоурология. 2015;11(3):71-78. DOI:10.17650/1726-9776-2015-11-3-71-78; Witjes J.A. (Chair), Bruins H.M., Cathomas R., Comperat E., Cowan N.C., Gakis G., Hernandez V., Lorch A., Ribal M.J. (Vicechair), Thalmann G.N, van der Heijden A.G., Veskimae E., Guidelines Associates: E. Linares Espinos, Rouanne M., Neuz-illet Y. Guidelines on Muscle-invasive and Metastatic Bladder Cancer. European Association of Urology; 2019. Pp. 34-39. ISBN 978-94-92671-07-3; Lee RK, Abol-Enein H, Artibani W, Bochner B, Dalbagni G, Daneshmand S, Fradet Y, Hautmann RE, Lee CT, Lerner SP, Pycha A, Sievert KD, Stenzl A, Thalmann G, Shariat SF. Urinary diversion after radical cystectomy for bladder cancer: options, patient selection, and outcomes. BJU Int. 2014;113(1):11-23. DOI:10.1111/bju.12121; Yang LS, Shan BL, Shan LL, Chin P, Murray S, Ahmadi N, Saxena A. A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer. Surg Oncol. 2016;25(3):281-97. DOI:10.1016/j.suronc.2016.05.027; Cerruto MA, D'Elia C, Siracusano S, Gedeshi X, Mariotto A, lafrate M, Niero M, Lonardi C, Bassi P, Belgrano E, Imbimbo C, Racioppi M, Talamini R, Ciciliato S, Toffoli L, Rizzo M, Visalli F, Verze P, Artibani W. Systematic review and meta-analysis of non RCT's on health related quality of life after radical cystectomy using validated questionnaires: Better results with orthotopic neobladder versus ileal conduit. Eur J Surg Oncol. 2016;42(3):343-60. DOI:10.1016/j.ejso.2015.10.001; Котов С.В., Хачатрян А.Л., Котова Д.П., Безруков Е.А., Про-стомолотов А.О., Носов А.К., Рева С.А., Семенов Д.В., Павлов В.Н., Измайлов А.А., Денейко А.С. Анализ результатов применения протокола ERAS в реальной клинической практике при радикальной цистэктомии (первое проспективное мультицентровое исследование в России) Урология. 2019;6:60-66. DOI:10.18565/urology.2019.6.60-66; Перепечай А.В., Васильев О.Н., Спицын И.М., Коган М.И. Предикторы морбидности радикальной цистэктомии и различных вариантов уродеривации: 20-летний опыт одного хирургического центра. Онкоурология. 2016;12(1):42-57. DOI:10.17650/1726-9776-2016-12-1-42-57; https://www.urovest.ru/jour/article/view/413

Διαθεσιμότητα: https://www.urovest.ru/jour/article/view/413
https://doi.org/10.21886/2308-6424-2021-9-1-47-55

Review of the article “Comparison of clips and electrosurgical instruments in sealing of lymphatic vessels during pelvic lymph node dissection at the time of radical cystectomy” ; Рецензия на статью «Профилактика развития лимфатических осложнений: сравнение клипс и электрохирургических инструментов при радикальной цистэктомии c тазовой лимфодиссекцией»

Συγγραφείς: К. М. Нюшко

Πηγή: Cancer Urology; Том 17, № 2 (2021); 103 ; Онкоурология; Том 17, № 2 (2021); 103 ; 1996-1812 ; 1726-9776

Θεματικοί όροι: электрохирургические инструменты, радикальная цистэктомия, тазовая лимфаденэктомия, лимфатические осложнения, клипсы

Περιγραφή αρχείου: application/pdf

Relation: https://oncourology.abvpress.ru/oncur/article/view/1447/1278; https://oncourology.abvpress.ru/oncur/article/view/1447

Διαθεσιμότητα: https://oncourology.abvpress.ru/oncur/article/view/1447
https://doi.org/10.17650/1726-9776-2021-17-2-103